| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.879 | 0.004 | 0.894 | Aldehyde oxidase inhibitor | 0.888 0.004 DBMET02068 0.894 0.003 DBMET02069 0.894 0.003 DBMET02070 | DBMET02070 | |
| 0.808 | 0.01 | 0.836 | Caspase 9 stimulant | 0.83 0.007 DBMET02068 0.836 0.007 DBMET02069 0.836 0.007 DBMET02070 | DBMET02070 | |
| 0.717 | 0.006 | 0.717 | 5 Hydroxytryptamine release stimulant | 0.612 0.013 DBMET02068 0.639 0.011 DBMET02069 0.639 0.011 DBMET02070 | ||
| 0.682 | 0.005 | 0.746 | Superoxide dismutase inhibitor | 0.729 0.004 DBMET02068 0.746 0.004 DBMET02069 0.746 0.004 DBMET02070 | DBMET02070 | |
| 0.668 | 0.003 | 0.685 | Peroxidase inhibitor | 0.685 0.003 DBMET02068 0.657 0.004 DBMET02069 0.657 0.004 DBMET02070 | DBMET02068 | |
| 0.654 | 0.003 | 0.654 | Alcohol oxidase inhibitor | 0.33 0.004 DBMET02068 0.246 0.005 DBMET02069 0.246 0.005 DBMET02070 | ||
| 0.614 | 0.006 | 0.614 | GABA C receptor rho-3 antagonist | 0.592 0.008 DBMET02068 0.566 0.012 DBMET02069 0.566 0.012 DBMET02070 | ||
| 0.608 | 0.01 | 0.608 | 5 Hydroxytryptamine release inhibitor | 0.566 0.016 DBMET02068 0.562 0.017 DBMET02069 0.562 0.017 DBMET02070 | ||
| 0.565 | 0.023 | 0.565 | Cholesterol antagonist | 0.519 0.03 DBMET02068 0.519 0.03 DBMET02069 0.519 0.03 DBMET02070 | ||
| 0.552 | 0.012 | 0.694 | Free radical scavenger | 0.691 0.005 DBMET02068 0.694 0.005 DBMET02069 0.694 0.005 DBMET02070 | DBMET02070 | |
| 0.532 | 0.004 | 0.532 | Tyrosine 3 hydroxylase inhibitor | 0.492 0.004 DBMET02068 0.457 0.005 DBMET02069 0.457 0.005 DBMET02070 | ||
| 0.538 | 0.016 | 0.659 | Antioxidant | 0.656 0.008 DBMET02068 0.659 0.008 DBMET02069 0.659 0.008 DBMET02070 | DBMET02070 | |
| 0.533 | 0.019 | 0.55 | Histamine release inhibitor | 0.55 0.016 DBMET02068 0.543 0.018 DBMET02069 0.543 0.018 DBMET02070 | DBMET02068 | |
| 0.529 | 0.016 | 0.642 | Caspase 3 stimulant | 0.614 0.009 DBMET02068 0.642 0.008 DBMET02069 0.642 0.008 DBMET02070 | DBMET02070 | |
| 0.521 | 0.012 | 0.687 | Amyloid beta aggregation inhibitor | 0.66 0.005 DBMET02068 0.687 0.005 DBMET02069 0.687 0.005 DBMET02070 | DBMET02070 | |
| 0.517 | 0.022 | 0.517 | Calcium channel L-type activator | 0.414 0.072 DBMET02068 0.378 0.097 DBMET02069 0.378 0.097 DBMET02070 | ||
| 0.552 | 0.06 | 0.682 | Apoptosis agonist | 0.657 0.038 DBMET02068 0.682 0.034 DBMET02069 0.682 0.034 DBMET02070 | DBMET02070 | |
| 0.493 | 0.004 | 0.546 | Cystathionine beta-synthase inhibitor | 0.546 0.003 DBMET02068 0.492 0.004 DBMET02069 0.492 0.004 DBMET02070 | DBMET02068 | |
| 0.481 | 0.008 | 0.689 | Tubulin antagonist | 0.598 0.005 DBMET02068 0.689 0.004 DBMET02069 0.689 0.004 DBMET02070 | DBMET02070 | |
| 0.477 | 0.005 | 0.499 | 5 Hydroxytryptamine uptake stimulant | 0.496 0.005 DBMET02068 0.499 0.004 DBMET02069 0.499 0.004 DBMET02070 | DBMET02070 | |
| 0.472 | 0.008 | 0.472 | Calcium channel activator | 0.447 0.012 DBMET02068 0.454 0.01 DBMET02069 0.454 0.01 DBMET02070 | ||
| 0.473 | 0.034 | 0.51 | Vasodilator, peripheral | 0.492 0.029 DBMET02068 0.51 0.026 DBMET02069 0.51 0.026 DBMET02070 | DBMET02070 | |
| 0.468 | 0.048 | 0.533 | 15-Lipoxygenase inhibitor | 0.53 0.035 DBMET02068 0.533 0.034 DBMET02069 0.533 0.034 DBMET02070 | DBMET02070 | |
| 0.427 | 0.008 | 0.483 | Amylase inhibitor | 0.471 0.007 DBMET02068 0.483 0.006 DBMET02069 0.483 0.006 DBMET02070 | DBMET02070 | |
| 0.429 | 0.013 | 0.429 | Anesthetic general | 0.372 0.02 DBMET02068 0.366 0.021 DBMET02069 0.366 0.021 DBMET02070 | ||
| 0.441 | 0.03 | 0.531 | 12-Lipoxygenase inhibitor | 0.5 0.021 DBMET02068 0.531 0.018 DBMET02069 0.531 0.018 DBMET02070 | DBMET02070 | |
| 0.46 | 0.051 | 0.524 | Transcription factor NF kappa B inhibitor | 0.502 0.044 DBMET02068 0.524 0.041 DBMET02069 0.524 0.041 DBMET02070 | DBMET02070 | |
| 0.411 | 0.011 | 0.446 | Melanin inhibitor | 0.446 0.009 DBMET02068 0.442 0.009 DBMET02069 0.442 0.009 DBMET02070 | DBMET02068 | |
| 0.423 | 0.025 | 0.455 | Hypoxia-inducible factor 1 alpha inhibitor | 0.452 0.02 DBMET02068 0.455 0.019 DBMET02069 0.455 0.019 DBMET02070 | DBMET02070 | |
| 0.403 | 0.009 | 0.403 | Alpha-N-acetylglucosaminidase inhibitor | 0.361 0.011 DBMET02068 0.321 0.014 DBMET02069 0.321 0.014 DBMET02070 | ||
| 0.396 | 0.005 | 0.396 | Estrogen antagonist | 0.24 0.009 DBMET02068 0.21 0.012 DBMET02069 0.21 0.012 DBMET02070 | ||
| 0.419 | 0.03 | 0.457 | Vasodilator, coronary | 0.437 0.026 DBMET02068 0.457 0.022 DBMET02069 0.457 0.022 DBMET02070 | DBMET02070 | |
| 0.392 | 0.004 | 0.392 | Estrogen receptor beta antagonist | 0.226 0.008 DBMET02068 0.19 0.01 DBMET02069 0.19 0.01 DBMET02070 | ||
| 0.42 | 0.034 | 0.508 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.492 0.021 DBMET02068 0.508 0.019 DBMET02069 0.508 0.019 DBMET02070 | DBMET02070 | |
| 0.393 | 0.008 | 0.413 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.413 0.007 DBMET02068 0.412 0.007 DBMET02069 0.412 0.007 DBMET02070 | DBMET02068 | |
| 0.4 | 0.02 | 0.431 | Pyruvate kinase inhibitor | 0.431 0.016 DBMET02068 0.419 0.017 DBMET02069 0.419 0.017 DBMET02070 | DBMET02068 | |
| 0.373 | 0.005 | 0.393 | Succinate dehydrogenase inhibitor | 0.388 0.004 DBMET02068 0.393 0.004 DBMET02069 0.393 0.004 DBMET02070 | DBMET02070 | |
| 0.402 | 0.037 | 0.468 | Lipoxygenase inhibitor | 0.458 0.025 DBMET02068 0.468 0.023 DBMET02069 0.468 0.023 DBMET02070 | DBMET02070 | |
| 0.382 | 0.023 | 0.382 | Sodium/bile acid cotransporter inhibitor | 0.335 0.05 DBMET02068 0.343 0.045 DBMET02069 0.343 0.045 DBMET02070 | ||
| 0.362 | 0.004 | 0.389 | Nitric-oxide synthase stimulant | 0.384 0.004 DBMET02068 0.389 0.004 DBMET02069 0.389 0.004 DBMET02070 | DBMET02070 | |
| 0.378 | 0.027 | 0.528 | Antimitotic | 0.456 0.016 DBMET02068 0.528 0.01 DBMET02069 0.528 0.01 DBMET02070 | DBMET02070 | |
| 0.445 | 0.097 | 0.524 | Alpha-glucosidase inhibitor | 0.511 0.078 DBMET02068 0.524 0.074 DBMET02069 0.524 0.074 DBMET02070 | DBMET02070 | |
| 0.37 | 0.022 | 0.405 | RNA-directed DNA polymerase inhibitor | 0.405 0.018 DBMET02068 0.394 0.019 DBMET02069 0.394 0.019 DBMET02070 | DBMET02068 | |
| 0.352 | 0.005 | 0.372 | Histidine decarboxylase inhibitor | 0.372 0.004 DBMET02068 0.356 0.005 DBMET02069 0.356 0.005 DBMET02070 | DBMET02068 | |
| 0.373 | 0.026 | 0.373 | Sigma receptor agonist | 0.154 0.083 DBMET02068 0.162 0.078 DBMET02069 0.162 0.078 DBMET02070 | ||
| 0.381 | 0.041 | 0.407 | Aryl hydrocarbon receptor agonist | 0.407 0.036 DBMET02068 0.403 0.037 DBMET02069 0.403 0.037 DBMET02070 | DBMET02068 | |
| 0.339 | 0.005 | 0.355 | Carbonic anhydrase XV inhibitor | 0.355 0.005 DBMET02068 0.346 0.005 DBMET02069 0.346 0.005 DBMET02070 | DBMET02068 | |
| 0.34 | 0.014 | 0.432 | Lipid peroxidase inhibitor | 0.432 0.008 DBMET02068 0.426 0.008 DBMET02069 0.426 0.008 DBMET02070 | DBMET02068 | |
| 0.413 | 0.09 | 0.413 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.386 0.113 DBMET02068 0.359 0.14 DBMET02069 0.359 0.14 DBMET02070 | ||
| 0.325 | 0.004 | 0.325 | GABA C receptor rho-2 antagonist | 0.302 0.005 DBMET02068 0.305 0.005 DBMET02069 0.305 0.005 DBMET02070 | ||
| 0.328 | 0.009 | 0.382 | NADPH oxidase inhibitor | 0.363 0.006 DBMET02068 0.382 0.005 DBMET02069 0.382 0.005 DBMET02070 | DBMET02070 | |
| 0.355 | 0.036 | 0.411 | Hypoglycemic | 0.411 0.026 DBMET02068 0.389 0.029 DBMET02069 0.389 0.029 DBMET02070 | DBMET02068 | |
| 0.327 | 0.008 | 0.327 | GABA C receptor agonist | 0.287 0.01 DBMET02068 0.251 0.013 DBMET02069 0.251 0.013 DBMET02070 | ||
| 0.328 | 0.009 | 0.328 | Aldehyde dehydrogenase inhibitor | 0.246 0.019 DBMET02068 0.215 0.024 DBMET02069 0.215 0.024 DBMET02070 | ||
| 0.342 | 0.028 | 0.399 | Cyclic AMP phosphodiesterase inhibitor | 0.373 0.021 DBMET02068 0.399 0.017 DBMET02069 0.399 0.017 DBMET02070 | DBMET02070 | |
| 0.318 | 0.004 | 0.341 | Macrophage migration inhibitory factor inhibitor | 0.341 0.004 DBMET02068 0.332 0.004 DBMET02069 0.332 0.004 DBMET02070 | DBMET02068 | |
| 0.312 | 0.005 | 0.312 | Estrogen agonist | 0.172 0.01 DBMET02068 0.142 0.012 DBMET02069 0.142 0.012 DBMET02070 | ||
| 0.321 | 0.013 | 0.351 | Neurotrophic factor enhancer | 0.342 0.01 DBMET02068 0.351 0.009 DBMET02069 0.351 0.009 DBMET02070 | DBMET02070 | |
| 0.347 | 0.04 | 0.417 | Antiamyloidogenic | 0.397 0.029 DBMET02068 0.417 0.026 DBMET02069 0.417 0.026 DBMET02070 | DBMET02070 | |
| 0.306 | 0.005 | 0.338 | Carbonic anhydrase III inhibitor | 0.337 0.005 DBMET02068 0.338 0.005 DBMET02069 0.338 0.005 DBMET02070 | DBMET02070 | |
| 0.316 | 0.021 | 0.369 | DNA methyltransferase I inhibitor | 0.341 0.015 DBMET02068 0.369 0.012 DBMET02069 0.369 0.012 DBMET02070 | DBMET02070 | |
| 0.299 | 0.005 | 0.483 | Beta tubulin antagonist | 0.399 0.004 DBMET02068 0.483 0.004 DBMET02069 0.483 0.004 DBMET02070 | DBMET02070 | |
| 0.308 | 0.017 | 0.37 | Monophenol monooxygenase inhibitor | 0.352 0.014 DBMET02068 0.37 0.013 DBMET02069 0.37 0.013 DBMET02070 | DBMET02070 | |
| 0.305 | 0.017 | 0.352 | Tumour necrosis factor antagonist | 0.324 0.014 DBMET02068 0.352 0.01 DBMET02069 0.352 0.01 DBMET02070 | DBMET02070 | |
| 0.329 | 0.043 | 0.329 | Insulysin inhibitor | 0.323 0.046 DBMET02068 0.323 0.046 DBMET02069 0.323 0.046 DBMET02070 | ||
| 0.289 | 0.004 | 0.527 | Alpha tubulin antagonist | 0.413 0.004 DBMET02068 0.527 0.004 DBMET02069 0.527 0.004 DBMET02070 | DBMET02070 | |
| 0.32 | 0.037 | 0.32 | DNA synthesis inhibitor | 0.274 0.054 DBMET02068 0.253 0.064 DBMET02069 0.253 0.064 DBMET02070 | ||
| 0.295 | 0.013 | 0.409 | M18 aspartyl aminopeptidase inhibitor | 0.409 0.005 DBMET02068 0.398 0.005 DBMET02069 0.398 0.005 DBMET02070 | DBMET02068 | |
| 0.308 | 0.026 | 0.358 | DNA methylase inhibitor | 0.334 0.02 DBMET02068 0.358 0.015 DBMET02069 0.358 0.015 DBMET02070 | DBMET02070 | |
| 0.307 | 0.025 | 0.307 | 5 Hydroxytryptamine 1E antagonist | 0.288 0.038 DBMET02068 0.285 0.041 DBMET02069 0.285 0.041 DBMET02070 | ||
| 0.286 | 0.004 | 0.314 | Creatine kinase inhibitor | 0.314 0.004 DBMET02068 0.282 0.004 DBMET02069 0.282 0.004 DBMET02070 | DBMET02068 | |
| 0.285 | 0.004 | 0.285 | CF transmembrane conductance regulator agonist | 0.265 0.005 DBMET02068 0.255 0.005 DBMET02069 0.255 0.005 DBMET02070 | ||
| 0.339 | 0.061 | 0.402 | Apoptosis antagonist | 0.402 0.038 DBMET02068 0.401 0.038 DBMET02069 0.401 0.038 DBMET02070 | DBMET02068 | |
| 0.298 | 0.02 | 0.299 | Interferon gamma antagonist | 0.299 0.02 DBMET02068 0.292 0.021 DBMET02069 0.292 0.021 DBMET02070 | DBMET02068 | |
| 0.321 | 0.044 | 0.345 | Transcription factor STAT3 inhibitor | 0.345 0.034 DBMET02068 0.342 0.036 DBMET02069 0.342 0.036 DBMET02070 | DBMET02068 | |
| 0.283 | 0.008 | 0.441 | Breast cancer-resistant protein inhibitor | 0.326 0.006 DBMET02068 0.441 0.005 DBMET02069 0.441 0.005 DBMET02070 | DBMET02070 | |
| 0.289 | 0.018 | 0.313 | Protein kinase stimulant | 0.312 0.015 DBMET02068 0.313 0.015 DBMET02069 0.313 0.015 DBMET02070 | DBMET02070 | |
| 0.316 | 0.047 | 0.334 | Transcription factor STAT inhibitor | 0.334 0.04 DBMET02068 0.325 0.043 DBMET02069 0.325 0.043 DBMET02070 | DBMET02068 | |
| 0.271 | 0.004 | 0.3 | Keratolytic | 0.288 0.004 DBMET02068 0.3 0.004 DBMET02069 0.3 0.004 DBMET02070 | DBMET02070 | |
| 0.309 | 0.044 | 0.331 | Interleukin agonist | 0.331 0.035 DBMET02068 0.328 0.036 DBMET02069 0.328 0.036 DBMET02070 | DBMET02068 | |
| 0.316 | 0.051 | 0.364 | DNA damaging | 0.344 0.043 DBMET02068 0.364 0.037 DBMET02069 0.364 0.037 DBMET02070 | DBMET02070 | |
| 0.274 | 0.01 | 0.331 | Interleukin 4 antagonist | 0.331 0.007 DBMET02068 0.317 0.008 DBMET02069 0.317 0.008 DBMET02070 | DBMET02068 | |
| 0.304 | 0.04 | 0.389 | Nitric oxide antagonist | 0.383 0.027 DBMET02068 0.389 0.027 DBMET02069 0.389 0.027 DBMET02070 | DBMET02070 | |
| 0.272 | 0.008 | 0.301 | Mannose-6-phosphate isomerase inhibitor | 0.301 0.005 DBMET02068 0.298 0.005 DBMET02069 0.298 0.005 DBMET02070 | DBMET02068 | |
| 0.274 | 0.012 | 0.274 | UDP-glucose 4-epimerase inhibitor | 0.239 0.014 DBMET02068 0.208 0.017 DBMET02069 0.208 0.017 DBMET02070 | ||
| 0.274 | 0.013 | 0.348 | 5-Lipoxygenase inhibitor | 0.348 0.007 DBMET02068 0.339 0.008 DBMET02069 0.339 0.008 DBMET02070 | DBMET02068 | |
| 0.306 | 0.051 | 0.457 | Tumour necrosis factor alpha release inhibitor | 0.391 0.028 DBMET02068 0.457 0.019 DBMET02069 0.457 0.019 DBMET02070 | DBMET02070 | |
| 0.274 | 0.021 | 0.274 | Phospholipase C inhibitor | 0.234 0.029 DBMET02068 0.215 0.036 DBMET02069 0.215 0.036 DBMET02070 | ||
| 0.316 | 0.064 | 0.358 | Spasmolytic | 0.345 0.054 DBMET02068 0.358 0.05 DBMET02069 0.358 0.05 DBMET02070 | DBMET02070 | |
| 0.255 | 0.008 | 0.291 | Carbonic anhydrase VI inhibitor | 0.279 0.007 DBMET02068 0.291 0.006 DBMET02069 0.291 0.006 DBMET02070 | DBMET02070 | |
| 0.268 | 0.022 | 0.291 | Topoisomerase II inhibitor | 0.277 0.021 DBMET02068 0.291 0.019 DBMET02069 0.291 0.019 DBMET02070 | DBMET02070 | |
| 0.254 | 0.008 | 0.254 | NADH dehydrogenase inhibitor | 0.224 0.009 DBMET02068 0.2 0.01 DBMET02069 0.2 0.01 DBMET02070 | ||
| 0.254 | 0.008 | 0.292 | Carbonic anhydrase XIII inhibitor | 0.278 0.007 DBMET02068 0.292 0.006 DBMET02069 0.292 0.006 DBMET02070 | DBMET02070 | |
| 0.254 | 0.009 | 0.256 | Toll-Like receptor 2 antagonist | 0.244 0.01 DBMET02068 0.256 0.008 DBMET02069 0.256 0.008 DBMET02070 | DBMET02070 | |
| 0.256 | 0.012 | 0.304 | Expectorant | 0.28 0.01 DBMET02068 0.304 0.008 DBMET02069 0.304 0.008 DBMET02070 | DBMET02070 | |
| 0.26 | 0.018 | 0.286 | Heat shock protein 90 antagonist | 0.286 0.012 DBMET02068 0.282 0.013 DBMET02069 0.282 0.013 DBMET02070 | DBMET02068 | |
| 0.294 | 0.052 | 0.294 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | 0.288 0.054 DBMET02068 0.272 0.058 DBMET02069 0.272 0.058 DBMET02070 | ||
| 0.314 | 0.073 | 0.314 | Streptokinase A inhibitor | 0.306 0.076 DBMET02068 0.296 0.081 DBMET02069 0.296 0.081 DBMET02070 | ||
| 0.248 | 0.01 | 0.248 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.218 0.013 DBMET02068 0.19 0.017 DBMET02069 0.19 0.017 DBMET02070 | ||
| 0.253 | 0.017 | 0.27 | Cholesterol synthesis inhibitor | 0.258 0.017 DBMET02068 0.27 0.015 DBMET02069 0.27 0.015 DBMET02070 | DBMET02070 | |
| 0.249 | 0.014 | 0.249 | ATPase inhibitor | 0.244 0.015 DBMET02068 0.24 0.016 DBMET02069 0.24 0.016 DBMET02070 | ||
| 0.258 | 0.024 | 0.258 | 3C-like protease (Human coronavirus) inhibitor | 0.209 0.047 DBMET02068 0.208 0.047 DBMET02069 0.208 0.047 DBMET02070 | ||
| 0.257 | 0.024 | 0.283 | Heat shock protein 90 alpha antagonist | 0.283 0.017 DBMET02068 0.274 0.02 DBMET02069 0.274 0.02 DBMET02070 | DBMET02068 | |
| 0.239 | 0.007 | 0.274 | Mucolytic | 0.258 0.006 DBMET02068 0.274 0.005 DBMET02069 0.274 0.005 DBMET02070 | DBMET02070 | |
| 0.268 | 0.036 | 0.282 | Non-steroidal antiinflammatory agent | 0.268 0.036 DBMET02068 0.282 0.032 DBMET02069 0.282 0.032 DBMET02070 | DBMET02070 | |
| 0.25 | 0.021 | 0.25 | Neurotensin receptor agonist | 0.216 0.028 DBMET02068 0.221 0.027 DBMET02069 0.221 0.027 DBMET02070 | ||
| 0.283 | 0.056 | 0.31 | Angiogenesis stimulant | 0.31 0.046 DBMET02068 0.303 0.048 DBMET02069 0.303 0.048 DBMET02070 | DBMET02068 | |
| 0.231 | 0.004 | 0.249 | DOPA decarboxylase inhibitor | 0.249 0.004 DBMET02068 0.233 0.004 DBMET02069 0.233 0.004 DBMET02070 | DBMET02068 | |
| 0.336 | 0.11 | 0.364 | Antibacterial | 0.364 0.094 DBMET02068 0.345 0.105 DBMET02069 0.345 0.105 DBMET02070 | DBMET02068 | |
| 0.262 | 0.037 | 0.319 | Dual specificity phosphatase 3 inhibitor | 0.319 0.025 DBMET02068 0.31 0.027 DBMET02069 0.31 0.027 DBMET02070 | DBMET02068 | |
| 0.232 | 0.008 | 0.232 | GABA C receptor antagonist | 0.211 0.011 DBMET02068 0.201 0.013 DBMET02069 0.201 0.013 DBMET02070 | ||
| 0.267 | 0.044 | 0.267 | ErbB-1 antagonist | 0.187 0.105 DBMET02068 0.228 0.064 DBMET02069 0.228 0.064 DBMET02070 | ||
| 0.234 | 0.011 | 0.243 | Cyclooxygenase 3 inhibitor | 0.238 0.01 DBMET02068 0.243 0.009 DBMET02069 0.243 0.009 DBMET02070 | DBMET02070 | |
| 0.241 | 0.019 | 0.241 | Hexokinase inhibitor | 0.235 0.02 DBMET02068 0.226 0.023 DBMET02069 0.226 0.023 DBMET02070 | ||
| 0.259 | 0.039 | 0.378 | P-glycoprotein inhibitor | 0.31 0.027 DBMET02068 0.378 0.018 DBMET02069 0.378 0.018 DBMET02070 | DBMET02070 | |
| 0.231 | 0.011 | 0.231 | Arachidonic acid antagonist | 0.23 0.012 DBMET02068 0.226 0.013 DBMET02069 0.226 0.013 DBMET02070 | ||
| 0.272 | 0.054 | 0.272 | Interleukin antagonist | 0.244 0.064 DBMET02068 0.231 0.069 DBMET02069 0.231 0.069 DBMET02070 | ||
| 0.253 | 0.036 | 0.26 | I kappa B kinase epsilon inhibitor | 0.254 0.036 DBMET02068 0.26 0.032 DBMET02069 0.26 0.032 DBMET02070 | DBMET02070 | |
| 0.269 | 0.052 | 0.269 | Psychostimulant | 0.26 0.055 DBMET02068 0.241 0.062 DBMET02069 0.241 0.062 DBMET02070 | ||
| 0.303 | 0.086 | 0.308 | Antithrombotic | 0.307 0.083 DBMET02068 0.308 0.083 DBMET02069 0.308 0.083 DBMET02070 | DBMET02070 | |
| 0.226 | 0.009 | 0.226 | Porphobilinogen synthase inhibitor | 0.194 0.013 DBMET02068 0.165 0.018 DBMET02069 0.165 0.018 DBMET02070 | ||
| 0.239 | 0.022 | 0.272 | Alkaline phosphatase inhibitor | 0.272 0.016 DBMET02068 0.262 0.018 DBMET02069 0.262 0.018 DBMET02070 | DBMET02068 | |
| 0.223 | 0.008 | 0.235 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.231 0.007 DBMET02068 0.235 0.007 DBMET02069 0.235 0.007 DBMET02070 | DBMET02070 | |
| 0.22 | 0.007 | 0.22 | Adenylate cyclase stimulant | 0.219 0.007 DBMET02068 0.218 0.008 DBMET02069 0.218 0.008 DBMET02070 | ||
| 0.218 | 0.006 | 0.218 | GABA C receptor rho-1 antagonist | 0.201 0.008 DBMET02068 0.197 0.009 DBMET02069 0.197 0.009 DBMET02070 | ||
| 0.218 | 0.006 | 0.218 | Prolactin inhibitor | 0.213 0.007 DBMET02068 0.195 0.01 DBMET02069 0.195 0.01 DBMET02070 | ||
| 0.246 | 0.037 | 0.256 | Insulin sensitizer | 0.256 0.031 DBMET02068 0.247 0.036 DBMET02069 0.247 0.036 DBMET02070 | DBMET02068 | |
| 0.271 | 0.063 | 0.271 | Dyrk kinase inhibitor | 0.263 0.066 DBMET02068 0.248 0.073 DBMET02069 0.248 0.073 DBMET02070 | ||
| 0.268 | 0.06 | 0.34 | Vasodilator | 0.331 0.039 DBMET02068 0.34 0.036 DBMET02069 0.34 0.036 DBMET02070 | DBMET02070 | |
| 0.242 | 0.036 | 0.261 | Amyloid beta precursor protein antagonist | 0.261 0.029 DBMET02068 0.257 0.03 DBMET02069 0.257 0.03 DBMET02070 | DBMET02068 | |
| 0.218 | 0.013 | 0.232 | Topoisomerase II alpha inhibitor | 0.215 0.013 DBMET02068 0.232 0.011 DBMET02069 0.232 0.011 DBMET02070 | DBMET02070 | |
| 0.209 | 0.004 | 0.209 | Glutamate release inhibitor | 0.173 0.006 DBMET02068 0.152 0.009 DBMET02069 0.152 0.009 DBMET02070 | ||
| 0.215 | 0.01 | 0.215 | Photosensitizer | 0.204 0.012 DBMET02068 0.19 0.015 DBMET02069 0.19 0.015 DBMET02070 | ||
| 0.234 | 0.03 | 0.316 | NOS3 expression enhancer | 0.316 0.015 DBMET02068 0.293 0.019 DBMET02069 0.293 0.019 DBMET02070 | DBMET02068 | |
| 0.246 | 0.044 | 0.308 | Hepatoprotectant | 0.304 0.028 DBMET02068 0.308 0.027 DBMET02069 0.308 0.027 DBMET02070 | DBMET02070 | |
| 0.206 | 0.005 | 0.211 | Heat shock protein 70 antagonist | 0.211 0.005 DBMET02068 0.209 0.005 DBMET02069 0.209 0.005 DBMET02070 | DBMET02068 | |
| 0.221 | 0.021 | 0.331 | Chelator | 0.331 0.009 DBMET02068 0.327 0.009 DBMET02069 0.327 0.009 DBMET02070 | DBMET02068 | |
| 0.202 | 0.003 | 0.218 | Granulocyte macrophage colony stimulating factor agonist | 0.214 0.003 DBMET02068 0.218 0.003 DBMET02069 0.218 0.003 DBMET02070 | DBMET02070 | |
| 0.208 | 0.01 | 0.249 | HIV-1 integrase (Overall Integration) inhibitor | 0.249 0.005 DBMET02068 0.229 0.007 DBMET02069 0.229 0.007 DBMET02070 | DBMET02068 | |
| 0.215 | 0.017 | 0.247 | Xanthine oxidase inhibitor | 0.247 0.013 DBMET02068 0.245 0.013 DBMET02069 0.245 0.013 DBMET02070 | DBMET02068 | |
| 0.231 | 0.035 | 0.245 | Histone acetyltransferase inhibitor | 0.244 0.028 DBMET02068 0.245 0.027 DBMET02069 0.245 0.027 DBMET02070 | DBMET02070 | |
| 0.218 | 0.022 | 0.226 | Topoisomerase I inhibitor | 0.212 0.024 DBMET02068 0.226 0.021 DBMET02069 0.226 0.021 DBMET02070 | DBMET02070 | |
| 0.207 | 0.013 | 0.207 | 5 Hydroxytryptamine 3A agonist | 0.154 0.033 DBMET02068 0.133 0.046 DBMET02069 0.133 0.046 DBMET02070 | ||
| 0.235 | 0.042 | 0.319 | Dual specificity phosphatase inhibitor | 0.319 0.026 DBMET02068 0.31 0.027 DBMET02069 0.31 0.027 DBMET02070 | DBMET02068 | |
| 0.226 | 0.034 | 0.237 | MAO inhibitor | 0.237 0.031 DBMET02068 0.229 0.033 DBMET02069 0.229 0.033 DBMET02070 | DBMET02068 | |
| 0.203 | 0.011 | 0.228 | Vanilloid 1 agonist | 0.215 0.009 DBMET02068 0.228 0.007 DBMET02069 0.228 0.007 DBMET02070 | DBMET02070 | |
| 0.201 | 0.01 | 0.201 | TRPA1 agonist | 0.174 0.018 DBMET02068 0.161 0.024 DBMET02069 0.161 0.024 DBMET02070 | ||
| 0.196 | 0.007 | 0.211 | Glutamate decarboxylase inhibitor | 0.211 0.006 DBMET02068 0.202 0.007 DBMET02069 0.202 0.007 DBMET02070 | DBMET02068 | |
| 0.2 | 0.013 | 0.231 | Beta glucuronidase inhibitor | 0.228 0.01 DBMET02068 0.231 0.01 DBMET02069 0.231 0.01 DBMET02070 | DBMET02070 | |
| 0.211 | 0.024 | 0.211 | Catenin beta inhibitor | 0.169 0.067 DBMET02068 0.162 0.081 DBMET02069 0.162 0.081 DBMET02070 | ||
| 0.292 | 0.106 | 0.331 | Prostaglandin dehydrogenase inhibitor | 0.331 0.089 DBMET02068 0.324 0.092 DBMET02069 0.324 0.092 DBMET02070 | DBMET02068 | |
| 0.19 | 0.005 | 0.19 | Estrogen receptor alpha agonist | 0.103 0.008 DBMET02068 0.093 0.01 DBMET02069 0.093 0.01 DBMET02070 | ||
| 0.205 | 0.02 | 0.225 | Farnesoid X receptor antagonist | 0.225 0.015 DBMET02068 0.205 0.02 DBMET02069 0.205 0.02 DBMET02070 | DBMET02068 | |
| 0.214 | 0.029 | 0.243 | Cyclooxygenase 1 inhibitor | 0.243 0.023 DBMET02068 0.23 0.025 DBMET02069 0.23 0.025 DBMET02070 | DBMET02068 | |
| 0.189 | 0.005 | 0.189 | Estrogen receptor beta agonist | 0.111 0.01 DBMET02068 0.093 0.012 DBMET02069 0.093 0.012 DBMET02070 | ||
| 0.187 | 0.003 | 0.187 | Estrogen-related receptor beta agonist | 0.152 0.004 DBMET02068 0.152 0.004 DBMET02069 0.152 0.004 DBMET02070 | ||
| 0.211 | 0.027 | 0.227 | MAO A inhibitor | 0.227 0.024 DBMET02068 0.219 0.026 DBMET02069 0.219 0.026 DBMET02070 | DBMET02068 | |
| 0.187 | 0.005 | 0.187 | Ca2+-transporting ATPase inhibitor | 0.182 0.006 DBMET02068 0.177 0.009 DBMET02069 0.177 0.009 DBMET02070 | ||
| 0.219 | 0.037 | 0.219 | 5 Hydroxytryptamine 3E antagonist | 0.208 0.05 DBMET02068 0.198 0.066 DBMET02069 0.198 0.066 DBMET02070 | ||
| 0.254 | 0.075 | 0.254 | Gastrin inhibitor | 0.233 0.1 DBMET02068 0.23 0.105 DBMET02069 0.23 0.105 DBMET02070 | ||
| 0.18 | 0.004 | 0.197 | D-Ala-D-Ala ligase inhibitor | 0.197 0.003 DBMET02068 0.18 0.004 DBMET02069 0.18 0.004 DBMET02070 | DBMET02068 | |
| 0.188 | 0.012 | 0.188 | Triose-phosphate isomerase inhibitor | 0.167 0.016 DBMET02068 0.148 0.02 DBMET02069 0.148 0.02 DBMET02070 | ||
| 0.192 | 0.016 | 0.192 | Potassium channel (Ca-activated) activator | 0.17 0.022 DBMET02068 0.134 0.034 DBMET02069 0.134 0.034 DBMET02070 | ||
| 0.181 | 0.008 | 0.181 | Phenylalanine 4-hydroxylase inhibitor | 0.175 0.009 DBMET02068 0.15 0.012 DBMET02069 0.15 0.012 DBMET02070 | ||
| 0.192 | 0.02 | 0.229 | Bronchodilator | 0.18 0.022 DBMET02068 0.229 0.015 DBMET02069 0.229 0.015 DBMET02070 | DBMET02070 | |
| 0.229 | 0.057 | 0.299 | Platelet adhesion inhibitor | 0.287 0.038 DBMET02068 0.299 0.034 DBMET02069 0.299 0.034 DBMET02070 | DBMET02070 | |
| 0.291 | 0.12 | 0.291 | Calpain 2 inhibitor | 0.231 0.163 DBMET02068 0.209 0.18 DBMET02069 0.209 0.18 DBMET02070 | ||
| 0.184 | 0.013 | 0.193 | Sphingomyelinase inhibitor | 0.184 0.013 DBMET02068 0.193 0.011 DBMET02069 0.193 0.011 DBMET02070 | DBMET02070 | |
| 0.192 | 0.022 | 0.206 | Microtubule formation inhibitor | 0.2 0.02 DBMET02068 0.206 0.018 DBMET02069 0.206 0.018 DBMET02070 | DBMET02070 | |
| 0.171 | 0.004 | 0.172 | GABA B receptor agonist | 0.171 0.004 DBMET02068 0.172 0.004 DBMET02069 0.172 0.004 DBMET02070 | DBMET02070 | |
| 0.236 | 0.07 | 0.236 | Neuropeptide Y2 antagonist | 0.189 0.141 DBMET02068 0.182 0.156 DBMET02069 0.182 0.156 DBMET02070 | ||
| 0.188 | 0.021 | 0.201 | Falcipain 3 inhibitor | 0.201 0.017 DBMET02068 0.185 0.022 DBMET02069 0.185 0.022 DBMET02070 | DBMET02068 | |
| 0.229 | 0.064 | 0.229 | MAP kinase kinase 2 inhibitor | 0.219 0.07 DBMET02068 0.206 0.078 DBMET02069 0.206 0.078 DBMET02070 | ||
| 0.181 | 0.018 | 0.181 | Adenylate kinase inhibitor | 0.163 0.022 DBMET02068 0.147 0.028 DBMET02069 0.147 0.028 DBMET02070 | ||
| 0.182 | 0.023 | 0.182 | Beta amyloid protein antagonist | 0.181 0.024 DBMET02068 0.171 0.028 DBMET02069 0.171 0.028 DBMET02070 | ||
| 0.204 | 0.046 | 0.204 | Cytidine deaminase inhibitor | 0.202 0.047 DBMET02068 0.204 0.046 DBMET02069 0.204 0.046 DBMET02070 | ||
| 0.16 | 0.003 | 0.16 | Ryanodine receptor antagonist | 0.143 0.003 DBMET02068 0.133 0.003 DBMET02069 0.133 0.003 DBMET02070 | ||
| 0.168 | 0.013 | 0.168 | Toll-Like receptor 4 antagonist | 0.158 0.017 DBMET02068 0.154 0.019 DBMET02069 0.154 0.019 DBMET02070 | ||
| 0.181 | 0.027 | 0.181 | Ferrochelatase inhibitor | 0.154 0.036 DBMET02068 0.13 0.047 DBMET02069 0.13 0.047 DBMET02070 | ||
| 0.312 | 0.159 | 0.376 | DNA polymerase beta inhibitor | 0.365 0.133 DBMET02068 0.376 0.129 DBMET02069 0.376 0.129 DBMET02070 | DBMET02070 | |
| 0.168 | 0.015 | 0.168 | Phosphofructokinase-1 inhibitor | 0.152 0.018 DBMET02068 0.136 0.021 DBMET02069 0.136 0.021 DBMET02070 | ||
| 0.156 | 0.005 | 0.156 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.102 0.01 DBMET02068 0.092 0.012 DBMET02069 0.092 0.012 DBMET02070 | ||
| 0.176 | 0.027 | 0.193 | Sphingosine 1-phosphate receptor 5 antagonist | 0.193 0.015 DBMET02068 0.185 0.02 DBMET02069 0.185 0.02 DBMET02070 | DBMET02068 | |
| 0.181 | 0.032 | 0.182 | Alkylator | 0.176 0.034 DBMET02068 0.182 0.032 DBMET02069 0.182 0.032 DBMET02070 | DBMET02070 | |
| 0.16 | 0.012 | 0.16 | Acetylcholine release stimulant | 0.146 0.019 DBMET02068 0.148 0.018 DBMET02069 0.148 0.018 DBMET02070 | ||
| 0.163 | 0.015 | 0.216 | Electron transport complex I inhibitor | 0.182 0.01 DBMET02068 0.216 0.007 DBMET02069 0.216 0.007 DBMET02070 | DBMET02070 | |
| 0.153 | 0.006 | 0.162 | Glycine receptor agonist | 0.162 0.005 DBMET02068 0.143 0.008 DBMET02069 0.143 0.008 DBMET02070 | DBMET02068 | |
| 0.169 | 0.022 | 0.169 | Catalase inhibitor | 0.121 0.033 DBMET02068 0.121 0.033 DBMET02069 0.121 0.033 DBMET02070 | ||
| 0.168 | 0.022 | 0.185 | Sphingosine 1-phosphate receptor 2 antagonist | 0.185 0.012 DBMET02068 0.181 0.014 DBMET02069 0.181 0.014 DBMET02070 | DBMET02068 | |
| 0.154 | 0.01 | 0.175 | Myeloperoxidase inhibitor | 0.174 0.008 DBMET02068 0.175 0.007 DBMET02069 0.175 0.007 DBMET02070 | DBMET02070 | |
| 0.243 | 0.099 | 0.243 | Immunostimulant | 0.231 0.104 DBMET02068 0.217 0.111 DBMET02069 0.217 0.111 DBMET02070 | ||
| 0.161 | 0.018 | 0.161 | Alcohol dehydrogenase inhibitor | 0.145 0.022 DBMET02068 0.143 0.023 DBMET02069 0.143 0.023 DBMET02070 | ||
| 0.175 | 0.031 | 0.175 | Nav1.6 sodium channel blocker | 0.156 0.048 DBMET02068 0.152 0.051 DBMET02069 0.152 0.051 DBMET02070 | ||
| 0.151 | 0.008 | 0.151 | GABA aminotransferase inhibitor | 0.127 0.013 DBMET02068 0.114 0.019 DBMET02069 0.114 0.019 DBMET02070 | ||
| 0.155 | 0.013 | 0.164 | Carbonic anhydrase V inhibitor | 0.163 0.012 DBMET02068 0.164 0.012 DBMET02069 0.164 0.012 DBMET02070 | DBMET02070 | |
| 0.16 | 0.018 | 0.174 | Urease inhibitor | 0.172 0.015 DBMET02068 0.174 0.014 DBMET02069 0.174 0.014 DBMET02070 | DBMET02070 | |
| 0.172 | 0.03 | 0.178 | MAO B inhibitor | 0.178 0.029 DBMET02068 0.171 0.031 DBMET02069 0.171 0.031 DBMET02070 | DBMET02068 | |
| 0.163 | 0.021 | 0.163 | DNA repair enzyme inhibitor | 0.159 0.024 DBMET02068 0.156 0.026 DBMET02069 0.156 0.026 DBMET02070 | ||
| 0.18 | 0.04 | 0.183 | Cell wall synthesis inhibitor | 0.183 0.038 DBMET02068 0.167 0.05 DBMET02069 0.167 0.05 DBMET02070 | DBMET02068 | |
| 0.156 | 0.015 | 0.156 | Anabolic | 0.15 0.018 DBMET02068 0.143 0.022 DBMET02069 0.143 0.022 DBMET02070 | ||
| 0.3 | 0.161 | 0.368 | DNA directed DNA polymerase inhibitor | 0.362 0.133 DBMET02068 0.368 0.13 DBMET02069 0.368 0.13 DBMET02070 | DBMET02070 | |
| 0.142 | 0.003 | 0.142 | Glutamate (mGluR7) antagonist | 0.126 0.004 DBMET02068 0.118 0.005 DBMET02069 0.118 0.005 DBMET02070 | ||
| 0.181 | 0.041 | 0.181 | Bone formation stimulant | 0.145 0.063 DBMET02068 0.147 0.061 DBMET02069 0.147 0.061 DBMET02070 | ||
| 0.163 | 0.024 | 0.163 | Papain-like protease (SARS coronavirus) inhibitor | 0.144 0.04 DBMET02068 0.145 0.039 DBMET02069 0.145 0.039 DBMET02070 | ||
| 0.189 | 0.051 | 0.251 | Protein-tyrosine phosphatase inhibitor | 0.251 0.031 DBMET02068 0.229 0.037 DBMET02069 0.229 0.037 DBMET02070 | DBMET02068 | |
| 0.187 | 0.05 | 0.187 | Phospholipase A2 inhibitor | 0.187 0.05 DBMET02068 0.174 0.057 DBMET02069 0.174 0.057 DBMET02070 | ||
| 0.142 | 0.004 | 0.142 | Estradiol 17 beta-dehydrogenase 2 inhibitor | 0.086 0.006 DBMET02068 0.074 0.007 DBMET02069 0.074 0.007 DBMET02070 | ||
| 0.173 | 0.036 | 0.173 | Neuropeptide Y1 antagonist | 0.144 0.075 DBMET02068 0.138 0.084 DBMET02069 0.138 0.084 DBMET02070 | ||
| 0.144 | 0.008 | 0.144 | Purinergic P2X1 antagonist | 0.131 0.009 DBMET02068 0.118 0.012 DBMET02069 0.118 0.012 DBMET02070 | ||
| 0.147 | 0.013 | 0.147 | Interleukin 12 antagonist | 0.12 0.029 DBMET02068 0.124 0.026 DBMET02069 0.124 0.026 DBMET02070 | ||
| 0.155 | 0.025 | 0.164 | AMP-activated protein kinase stimulant | 0.164 0.02 DBMET02068 0.164 0.02 DBMET02069 0.164 0.02 DBMET02070 | DBMET02070 | |
| 0.142 | 0.013 | 0.142 | Estrogen receptor alpha antagonist | 0.138 0.014 DBMET02068 0.127 0.016 DBMET02069 0.127 0.016 DBMET02070 | ||
| 0.155 | 0.026 | 0.155 | Antineoplastic alkaloid | 0.128 0.034 DBMET02068 0.127 0.035 DBMET02069 0.127 0.035 DBMET02070 | ||
| 0.157 | 0.028 | 0.157 | Sphingosine 1-phosphate receptor 4 antagonist | 0.138 0.045 DBMET02068 0.13 0.055 DBMET02069 0.13 0.055 DBMET02070 | ||
| 0.157 | 0.028 | 0.157 | Protein kinase C gamma inhibitor | 0.145 0.034 DBMET02068 0.144 0.035 DBMET02069 0.144 0.035 DBMET02070 | ||
| 0.222 | 0.093 | 0.222 | Calpain inhibitor | 0.21 0.104 DBMET02068 0.198 0.116 DBMET02069 0.198 0.116 DBMET02070 | ||
| 0.212 | 0.085 | 0.212 | Peptidyltransferase inhibitor | 0.207 0.09 DBMET02068 0.209 0.088 DBMET02069 0.209 0.088 DBMET02070 | ||
| 0.14 | 0.013 | 0.147 | Carbonic anhydrase VA inhibitor | 0.146 0.012 DBMET02068 0.147 0.011 DBMET02069 0.147 0.011 DBMET02070 | DBMET02070 | |
| 0.163 | 0.037 | 0.175 | Antibacterial (Helicobacter pylori) | 0.173 0.031 DBMET02068 0.175 0.03 DBMET02069 0.175 0.03 DBMET02070 | DBMET02070 | |
| 0.134 | 0.007 | 0.134 | Estradiol 17 beta-dehydrogenase inhibitor | 0.123 0.008 DBMET02068 0.115 0.009 DBMET02069 0.115 0.009 DBMET02070 | ||
| 0.17 | 0.044 | 0.237 | Acetylcholinesterase inhibitor | 0.2 0.033 DBMET02068 0.237 0.024 DBMET02069 0.237 0.024 DBMET02070 | DBMET02070 | |
| 0.164 | 0.04 | 0.164 | MAP kinase kinase 4 inhibitor | |||
| 0.162 | 0.038 | 0.162 | Cathepsin H inhibitor | 0.136 0.058 DBMET02068 0.122 0.073 DBMET02069 0.122 0.073 DBMET02070 | ||
| 0.129 | 0.005 | 0.155 | Heat shock protein 90 beta antagonist | 0.155 0.004 DBMET02068 0.155 0.004 DBMET02069 0.155 0.004 DBMET02070 | DBMET02070 | |
| 0.16 | 0.038 | 0.16 | Pregnane X receptor agonist | 0.15 0.052 DBMET02068 0.144 0.065 DBMET02069 0.144 0.065 DBMET02070 | ||
| 0.175 | 0.053 | 0.197 | Cyclooxygenase inhibitor | 0.197 0.043 DBMET02068 0.182 0.049 DBMET02069 0.182 0.049 DBMET02070 | DBMET02068 | |
| 0.136 | 0.015 | 0.136 | Purinergic P2X2 antagonist | 0.127 0.018 DBMET02068 0.13 0.017 DBMET02069 0.13 0.017 DBMET02070 | ||
| 0.159 | 0.039 | 0.159 | Adenylate cyclase inhibitor | 0.156 0.041 DBMET02068 0.136 0.055 DBMET02069 0.136 0.055 DBMET02070 | ||
| 0.13 | 0.011 | 0.14 | Carbonic anhydrase VB inhibitor | 0.14 0.01 DBMET02068 0.129 0.011 DBMET02069 0.129 0.011 DBMET02070 | DBMET02068 | |
| 0.136 | 0.018 | 0.136 | Lanosterol 14 alpha demethylase inhibitor | 0.111 0.04 DBMET02068 0.098 0.059 DBMET02069 0.098 0.059 DBMET02070 | ||
| 0.155 | 0.037 | 0.206 | Interleukin 1b antagonist | 0.205 0.018 DBMET02068 0.206 0.018 DBMET02069 0.206 0.018 DBMET02070 | DBMET02070 | |
| 0.126 | 0.009 | 0.126 | Beta 3 adrenoreceptor antagonist | 0.117 0.01 DBMET02068 0.114 0.011 DBMET02069 0.114 0.011 DBMET02070 | ||
| 0.136 | 0.018 | 0.14 | Glutamate (mGluR7) agonist | 0.134 0.019 DBMET02068 0.14 0.016 DBMET02069 0.14 0.016 DBMET02070 | DBMET02070 | |
| 0.136 | 0.019 | 0.136 | Adrenaline agonist | 0.128 0.022 DBMET02068 0.123 0.024 DBMET02069 0.123 0.024 DBMET02070 | ||
| 0.119 | 0.004 | 0.119 | Dopamine D5 agonist | 0.111 0.004 DBMET02068 0.115 0.004 DBMET02069 0.115 0.004 DBMET02070 | ||
| 0.138 | 0.023 | 0.138 | Protein kinase C zeta inhibitor | 0.133 0.025 DBMET02068 0.135 0.024 DBMET02069 0.135 0.024 DBMET02070 | ||
| 0.137 | 0.022 | 0.189 | Phosphodiesterase 4D inhibitor | 0.117 0.03 DBMET02068 0.189 0.012 DBMET02069 0.189 0.012 DBMET02070 | DBMET02070 | |
| 0.128 | 0.014 | 0.132 | Bile acid receptor antagonist | 0.132 0.012 DBMET02068 0.125 0.016 DBMET02069 0.125 0.016 DBMET02070 | DBMET02068 | |
| 0.124 | 0.011 | 0.136 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.136 0.009 DBMET02068 0.131 0.01 DBMET02069 0.131 0.01 DBMET02070 | DBMET02068 | |
| 0.315 | 0.202 | 0.46 | Antiinflammatory | 0.46 0.105 DBMET02068 0.436 0.118 DBMET02069 0.436 0.118 DBMET02070 | DBMET02068 | |
| 0.242 | 0.129 | 0.263 | Thyroid hormone antagonist | 0.261 0.116 DBMET02068 0.263 0.115 DBMET02069 0.263 0.115 DBMET02070 | DBMET02070 | |
| 0.15 | 0.038 | 0.15 | Aminopeptidase B inhibitor | 0.121 0.052 DBMET02068 0.106 0.061 DBMET02069 0.106 0.061 DBMET02070 | ||
| 0.129 | 0.017 | 0.271 | HIV-1 integrase (3'-Processing) inhibitor | 0.271 0.005 DBMET02068 0.266 0.006 DBMET02069 0.266 0.006 DBMET02070 | DBMET02068 | |
| 0.147 | 0.036 | 0.149 | Interleukin 8 antagonist | 0.149 0.034 DBMET02068 0.147 0.036 DBMET02069 0.147 0.036 DBMET02070 | DBMET02068 | |
| 0.141 | 0.03 | 0.141 | Transcription factor STAT6 inhibitor | 0.137 0.035 DBMET02068 0.131 0.043 DBMET02069 0.131 0.043 DBMET02070 | ||
| 0.116 | 0.005 | 0.116 | MAP kinase kinase 7 inhibitor | 0.102 0.011 DBMET02068 0.099 0.014 DBMET02069 0.099 0.014 DBMET02070 | ||
| 0.124 | 0.015 | 0.124 | Carbamoyl phosphate synthetase inhibitor | 0.112 0.017 DBMET02068 0.1 0.021 DBMET02069 0.1 0.021 DBMET02070 | ||
| 0.278 | 0.168 | 0.294 | Transcription factor inhibitor | 0.29 0.16 DBMET02068 0.294 0.158 DBMET02069 0.294 0.158 DBMET02070 | DBMET02070 | |
| 0.178 | 0.068 | 0.263 | Mcl-1 antagonist | 0.263 0.031 DBMET02068 0.25 0.036 DBMET02069 0.25 0.036 DBMET02070 | DBMET02068 | |
| 0.125 | 0.016 | 0.224 | Vanilloid agonist | 0.19 0.007 DBMET02068 0.224 0.005 DBMET02069 0.224 0.005 DBMET02070 | DBMET02070 | |
| 0.12 | 0.011 | 0.139 | Xanthine dehydrogenase inhibitor | 0.139 0.008 DBMET02068 0.131 0.009 DBMET02069 0.131 0.009 DBMET02070 | DBMET02068 | |
| 0.169 | 0.062 | 0.169 | Cyclin-dependent kinase 3 inhibitor | 0.147 0.103 DBMET02068 | ||
| 0.113 | 0.006 | 0.113 | Potassium channel Kv1.3 blocker | 0.087 0.01 DBMET02068 0.074 0.014 DBMET02069 0.074 0.014 DBMET02070 | ||
| 0.152 | 0.045 | 0.205 | Protein-tyrosine phosphatase 1B inhibitor | 0.205 0.028 DBMET02068 0.183 0.034 DBMET02069 0.183 0.034 DBMET02070 | DBMET02068 | |
| 0.162 | 0.056 | 0.162 | Toll-Like receptor 9 antagonist | 0.138 0.071 DBMET02068 0.156 0.059 DBMET02069 0.156 0.059 DBMET02070 | ||
| 0.17 | 0.064 | 0.203 | Interleukin 6 antagonist | 0.2 0.04 DBMET02068 0.203 0.039 DBMET02069 0.203 0.039 DBMET02070 | DBMET02070 | |
| 0.153 | 0.047 | 0.225 | DNA polymerase I inhibitor | 0.225 0.021 DBMET02068 0.223 0.022 DBMET02069 0.223 0.022 DBMET02070 | DBMET02068 | |
| 0.153 | 0.048 | 0.176 | Anesthetic local | 0.174 0.04 DBMET02068 0.176 0.039 DBMET02069 0.176 0.039 DBMET02070 | DBMET02070 | |
| 0.125 | 0.021 | 0.13 | Phosphodiesterase 6D inhibitor | 0.13 0.018 DBMET02068 0.128 0.019 DBMET02069 0.128 0.019 DBMET02070 | DBMET02068 | |
| 0.109 | 0.005 | 0.109 | Calcium channel P-type blocker | 0.098 0.006 DBMET02068 0.105 0.005 DBMET02069 0.105 0.005 DBMET02070 | ||
| 0.129 | 0.026 | 0.14 | Thioredoxin inhibitor | 0.138 0.021 DBMET02068 0.14 0.02 DBMET02069 0.14 0.02 DBMET02070 | DBMET02070 | |
| 0.107 | 0.005 | 0.119 | Transcription factor RelA inhibitor | 0.115 0.004 DBMET02068 0.119 0.004 DBMET02069 0.119 0.004 DBMET02070 | DBMET02070 | |
| 0.242 | 0.14 | 0.275 | Thioredoxin glutathione reductase inhibitor | 0.274 0.119 DBMET02068 0.275 0.118 DBMET02069 0.275 0.118 DBMET02070 | DBMET02070 | |
| 0.136 | 0.034 | 0.187 | Multidrug resistance-associated protein 1 inhibitor | 0.164 0.02 DBMET02068 0.187 0.013 DBMET02069 0.187 0.013 DBMET02070 | DBMET02070 | |
| 0.12 | 0.018 | 0.12 | mTOR complex 2 inhibitor | 0.114 0.021 DBMET02068 0.11 0.024 DBMET02069 0.11 0.024 DBMET02070 | ||
| 0.118 | 0.017 | 0.118 | Potassium channel large-conductance Ca-activated activator | 0.077 0.037 DBMET02068 | ||
| 0.11 | 0.009 | 0.119 | Carbonic anhydrase XIV inhibitor | 0.115 0.008 DBMET02068 0.119 0.007 DBMET02069 0.119 0.007 DBMET02070 | DBMET02070 | |
| 0.136 | 0.036 | 0.139 | Mediator release inhibitor | 0.139 0.034 DBMET02068 0.139 0.034 DBMET02069 0.139 0.034 DBMET02070 | DBMET02070 | |
| 0.138 | 0.038 | 0.138 | Caspase 3 inhibitor | 0.13 0.046 DBMET02068 0.122 0.057 DBMET02069 0.122 0.057 DBMET02070 | ||
| 0.112 | 0.012 | 0.119 | Beta adrenoreceptor antagonist | 0.114 0.012 DBMET02068 0.119 0.01 DBMET02069 0.119 0.01 DBMET02070 | DBMET02070 | |
| 0.248 | 0.149 | 0.251 | Immunosuppressant | 0.251 0.147 DBMET02068 0.238 0.158 DBMET02069 0.238 0.158 DBMET02070 | DBMET02068 | |
| 0.129 | 0.03 | 0.129 | Calcium antagonist | 0.11 0.041 DBMET02068 0.12 0.035 DBMET02069 0.12 0.035 DBMET02070 | ||
| 0.12 | 0.023 | 0.12 | Glutamate dehydrogenase inhibitor | 0.107 0.027 DBMET02068 0.095 0.033 DBMET02069 0.095 0.033 DBMET02070 | ||
| 0.11 | 0.013 | 0.11 | CC chemokine 5 receptor agonist | 0.091 0.035 DBMET02068 0.085 0.049 DBMET02069 0.085 0.049 DBMET02070 | ||
| 0.127 | 0.03 | 0.127 | Interleukin 1 beta converting enzyme inhibitor | 0.109 0.046 DBMET02068 0.097 0.061 DBMET02069 0.097 0.061 DBMET02070 | ||
| 0.127 | 0.03 | 0.152 | Phosphodiesterase IV inhibitor | 0.117 0.034 DBMET02068 0.152 0.022 DBMET02069 0.152 0.022 DBMET02070 | DBMET02070 | |
| 0.115 | 0.019 | 0.118 | Leukotriene synthesis inhibitor | 0.118 0.017 DBMET02068 0.111 0.021 DBMET02069 0.111 0.021 DBMET02070 | DBMET02068 | |
| 0.117 | 0.022 | 0.126 | ATPase (Vacuolar H+) inhibitor | 0.125 0.017 DBMET02068 0.126 0.016 DBMET02069 0.126 0.016 DBMET02070 | DBMET02070 | |
| 0.102 | 0.007 | 0.102 | Cyclin D1 inhibitor | 0.101 0.008 DBMET02068 0.094 0.01 DBMET02069 0.094 0.01 DBMET02070 | ||
| 0.227 | 0.133 | 0.248 | Thyroid hormone beta antagonist | 0.245 0.122 DBMET02068 0.248 0.119 DBMET02069 0.248 0.119 DBMET02070 | DBMET02070 | |
| 0.122 | 0.028 | 0.122 | Histamine N-methyltransferase inhibitor | 0.091 0.054 DBMET02068 0.082 0.064 DBMET02069 0.082 0.064 DBMET02070 | ||
| 0.097 | 0.005 | 0.097 | Dihydropteroate synthase inhibitor | 0.083 0.006 DBMET02068 0.08 0.006 DBMET02069 0.08 0.006 DBMET02070 | ||
| 0.097 | 0.004 | 0.097 | Adenylate cyclase 1 inhibitor | 0.082 0.007 DBMET02068 0.072 0.011 DBMET02069 0.072 0.011 DBMET02070 | ||
| 0.119 | 0.026 | 0.121 | Ornithine decarboxylase inhibitor | 0.121 0.025 DBMET02068 0.12 0.026 DBMET02069 0.12 0.026 DBMET02070 | DBMET02068 | |
| 0.105 | 0.013 | 0.105 | 5 Hydroxytryptamine 2A agonist | 0.082 0.026 DBMET02068 0.076 0.031 DBMET02069 0.076 0.031 DBMET02070 | ||
| 0.125 | 0.033 | 0.125 | Electrolyte absorption antagonist | 0.111 0.045 DBMET02068 0.098 0.061 DBMET02069 0.098 0.061 DBMET02070 | ||
| 0.124 | 0.031 | 0.124 | Androgen antagonist | 0.11 0.039 DBMET02068 0.1 0.047 DBMET02069 0.1 0.047 DBMET02070 | ||
| 0.111 | 0.019 | 0.155 | HIV-1 integrase inhibitor | 0.155 0.008 DBMET02068 0.145 0.009 DBMET02069 0.145 0.009 DBMET02070 | DBMET02068 | |
| 0.116 | 0.025 | 0.123 | Glutathione S-transferase inhibitor | 0.123 0.021 DBMET02068 0.118 0.024 DBMET02069 0.118 0.024 DBMET02070 | DBMET02068 | |
| 0.128 | 0.038 | 0.128 | Gastric antisecretory | 0.125 0.039 DBMET02068 0.119 0.043 DBMET02069 0.119 0.043 DBMET02070 | ||
| 0.286 | 0.196 | 0.331 | MAP kinase 1 inhibitor | 0.304 0.175 DBMET02068 0.331 0.15 DBMET02069 0.331 0.15 DBMET02070 | DBMET02070 | |
| 0.099 | 0.01 | 0.099 | Exportin-1 inhibitor | 0.086 0.019 DBMET02068 0.085 0.02 DBMET02069 0.085 0.02 DBMET02070 | ||
| 0.108 | 0.02 | 0.235 | HIV-1 integrase (Strand Transfer) inhibitor | 0.235 0.007 DBMET02068 0.23 0.007 DBMET02069 0.23 0.007 DBMET02070 | DBMET02068 | |
| 0.109 | 0.02 | 0.109 | Caspase 7 inhibitor | 0.101 0.027 DBMET02068 0.094 0.036 DBMET02069 0.094 0.036 DBMET02070 | ||
| 0.092 | 0.004 | 0.092 | Pregnane X receptor antagonist | 0.086 0.005 DBMET02068 0.08 0.007 DBMET02069 0.08 0.007 DBMET02070 | ||
| 0.147 | 0.06 | 0.209 | Interleukin 1 antagonist | 0.209 0.029 DBMET02068 0.207 0.03 DBMET02069 0.207 0.03 DBMET02070 | DBMET02068 | |
| 0.096 | 0.01 | 0.106 | Topoisomerase II beta inhibitor | 0.1 0.009 DBMET02068 0.106 0.008 DBMET02069 0.106 0.008 DBMET02070 | DBMET02070 | |
| 0.093 | 0.007 | 0.115 | Glucose-6-phosphate translocase inhibitor | 0.11 0.005 DBMET02068 0.115 0.005 DBMET02069 0.115 0.005 DBMET02070 | DBMET02070 | |
| 0.108 | 0.023 | 0.118 | Dopamine D1 antagonist | 0.113 0.021 DBMET02068 0.118 0.02 DBMET02069 0.118 0.02 DBMET02070 | DBMET02070 | |
| 0.089 | 0.004 | 0.089 | Dopamine beta hydroxylase inhibitor | 0.081 0.005 DBMET02068 0.073 0.007 DBMET02069 0.073 0.007 DBMET02070 | ||
| 0.088 | 0.003 | 0.09 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.09 0.003 DBMET02068 0.082 0.004 DBMET02069 0.082 0.004 DBMET02070 | DBMET02068 | |
| 0.108 | 0.024 | 0.108 | Na+ K+ transporting ATPase inhibitor | 0.105 0.027 DBMET02068 0.101 0.03 DBMET02069 0.101 0.03 DBMET02070 | ||
| 0.098 | 0.015 | 0.098 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.088 0.017 DBMET02068 0.078 0.021 DBMET02069 0.078 0.021 DBMET02070 | ||
| 0.113 | 0.029 | 0.113 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | 0.093 0.045 DBMET02068 0.085 0.056 DBMET02069 0.085 0.056 DBMET02070 | ||
| 0.101 | 0.018 | 0.101 | Biliverdin reductase inhibitor | 0.087 0.023 DBMET02068 0.075 0.029 DBMET02069 0.075 0.029 DBMET02070 | ||
| 0.099 | 0.016 | 0.099 | Potassium channel (ATP-sensitive) blocker | 0.099 0.016 DBMET02068 0.089 0.021 DBMET02069 0.089 0.021 DBMET02070 | ||
| 0.101 | 0.019 | 0.101 | Acetylcholine M5 receptor agonist | 0.089 0.027 DBMET02068 0.08 0.034 DBMET02069 0.08 0.034 DBMET02070 | ||
| 0.092 | 0.01 | 0.092 | Aconitate hydratase inhibitor | 0.082 0.013 DBMET02068 0.073 0.017 DBMET02069 0.073 0.017 DBMET02070 | ||
| 0.175 | 0.093 | 0.175 | Focal adhesion kinase 2 inhibitor | 0.172 0.097 DBMET02068 0.172 0.098 DBMET02069 0.172 0.098 DBMET02070 | ||
| 0.086 | 0.005 | 0.086 | Estradiol 17 beta-dehydrogenase 3 inhibitor | 0.067 0.007 DBMET02068 0.061 0.008 DBMET02069 0.061 0.008 DBMET02070 | ||
| 0.161 | 0.079 | 0.161 | Growth hormone agonist | |||
| 0.093 | 0.012 | 0.096 | Beta 1 adrenoreceptor antagonist | 0.093 0.012 DBMET02068 0.096 0.011 DBMET02069 0.096 0.011 DBMET02070 | DBMET02070 | |
| 0.131 | 0.05 | 0.131 | Alpha 2b adrenoreceptor antagonist | 0.12 0.058 DBMET02068 0.126 0.053 DBMET02069 0.126 0.053 DBMET02070 | ||
| 0.15 | 0.07 | 0.15 | CDC-like kinase 1 inhibitor | 0.113 0.102 DBMET02068 | ||
| 0.162 | 0.081 | 0.175 | Death-associated protein kinase 2 inhibitor | 0.175 0.06 DBMET02068 0.159 0.087 DBMET02069 0.159 0.087 DBMET02070 | DBMET02068 | |
| 0.094 | 0.013 | 0.094 | Glutamate (mGluR6) antagonist | 0.087 0.018 DBMET02068 0.081 0.023 DBMET02069 0.081 0.023 DBMET02070 | ||
| 0.105 | 0.025 | 0.107 | Thioredoxin reductase inhibitor | 0.107 0.023 DBMET02068 0.107 0.023 DBMET02069 0.107 0.023 DBMET02070 | DBMET02070 | |
| 0.087 | 0.007 | 0.087 | Glucose-6-phosphate isomerase inhibitor | 0.081 0.008 DBMET02068 0.075 0.01 DBMET02069 0.075 0.01 DBMET02070 | ||
| 0.087 | 0.008 | 0.095 | Squalene epoxidase inhibitor | 0.095 0.006 DBMET02068 0.084 0.008 DBMET02069 0.084 0.008 DBMET02070 | DBMET02068 | |
| 0.096 | 0.017 | 0.096 | Acyl-CoA dehydrogenase inhibitor | 0.083 0.021 DBMET02068 0.072 0.026 DBMET02069 0.072 0.026 DBMET02070 | ||
| 0.097 | 0.018 | 0.132 | Aldose reductase inhibitor | 0.132 0.013 DBMET02068 0.124 0.014 DBMET02069 0.124 0.014 DBMET02070 | DBMET02068 | |
| 0.088 | 0.01 | 0.088 | 5 Hydroxytryptamine 7 agonist | 0.067 0.022 DBMET02068 0.069 0.02 DBMET02069 0.069 0.02 DBMET02070 | ||
| 0.108 | 0.029 | 0.108 | Opioid kappa receptor antagonist | |||
| 0.116 | 0.038 | 0.116 | Opioid antagonist | |||
| 0.089 | 0.011 | 0.101 | Sphingosine kinase 2 inhibitor | 0.101 0.007 DBMET02068 0.092 0.01 DBMET02069 0.092 0.01 DBMET02070 | DBMET02068 | |
| 0.087 | 0.009 | 0.087 | Alpha-mannosidase inhibitor | 0.075 0.013 DBMET02068 0.069 0.017 DBMET02069 0.069 0.017 DBMET02070 | ||
| 0.148 | 0.071 | 0.158 | Hemostatic | 0.158 0.059 DBMET02068 0.154 0.063 DBMET02069 0.154 0.063 DBMET02070 | DBMET02068 | |
| 0.14 | 0.063 | 0.15 | Toll-Like receptor antagonist | 0.138 0.065 DBMET02068 0.15 0.056 DBMET02069 0.15 0.056 DBMET02070 | DBMET02070 | |
| 0.104 | 0.029 | 0.104 | Glycine receptor antagonist | 0.093 0.039 DBMET02068 0.09 0.043 DBMET02069 0.09 0.043 DBMET02070 | ||
| 0.098 | 0.022 | 0.098 | Aromatase inhibitor | 0.09 0.024 DBMET02068 0.082 0.026 DBMET02069 0.082 0.026 DBMET02070 | ||
| 0.115 | 0.04 | 0.115 | MAP kinase kinase 1 inhibitor | 0.111 0.044 DBMET02068 0.107 0.048 DBMET02069 0.107 0.048 DBMET02070 | ||
| 0.097 | 0.022 | 0.103 | Phosphodiesterase VI inhibitor | 0.103 0.018 DBMET02068 0.102 0.019 DBMET02069 0.102 0.019 DBMET02070 | DBMET02068 | |
| 0.079 | 0.003 | 0.079 | Estrogen-related receptor beta antagonist | 0.05 0.005 DBMET02068 0.045 0.008 DBMET02069 0.045 0.008 DBMET02070 | ||
| 0.092 | 0.017 | 0.093 | Aryl hydrocarbon receptor antagonist | 0.093 0.017 DBMET02068 0.092 0.018 DBMET02069 0.092 0.018 DBMET02070 | DBMET02068 | |
| 0.079 | 0.005 | 0.079 | Alpha 1d adrenoreceptor agonist | 0.074 0.006 DBMET02068 0.065 0.009 DBMET02069 0.065 0.009 DBMET02070 | ||
| 0.099 | 0.025 | 0.099 | Sphingosine 1-phosphate receptor 4 agonist | 0.073 0.042 DBMET02068 0.064 0.05 DBMET02069 0.064 0.05 DBMET02070 | ||
| 0.092 | 0.018 | 0.092 | Androgen agonist | 0.07 0.03 DBMET02068 0.062 0.039 DBMET02069 0.062 0.039 DBMET02070 | ||
| 0.12 | 0.049 | 0.121 | Alpha 2c adrenoreceptor antagonist | 0.113 0.055 DBMET02068 0.121 0.049 DBMET02069 0.121 0.049 DBMET02070 | DBMET02070 | |
| 0.147 | 0.077 | 0.147 | Acetylcholine M1 receptor antagonist | 0.129 0.096 DBMET02068 0.118 0.112 DBMET02069 0.118 0.112 DBMET02070 | ||
| 0.104 | 0.034 | 0.104 | CYP2A6 inhibitor | 0.071 0.058 DBMET02068 | ||
| 0.128 | 0.059 | 0.136 | Proteasome inhibitor | 0.136 0.054 DBMET02068 0.133 0.057 DBMET02069 0.133 0.057 DBMET02070 | DBMET02068 | |
| 0.098 | 0.029 | 0.098 | Aminopeptidase I inhibitor | 0.08 0.042 DBMET02068 0.073 0.05 DBMET02069 0.073 0.05 DBMET02070 | ||
| 0.106 | 0.038 | 0.109 | Phosphodiesterase I inhibitor | 0.104 0.04 DBMET02068 0.109 0.035 DBMET02069 0.109 0.035 DBMET02070 | DBMET02070 | |
| 0.222 | 0.154 | 0.222 | Interleukin 2 agonist | |||
| 0.09 | 0.023 | 0.09 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.084 0.03 DBMET02068 0.078 0.04 DBMET02069 0.078 0.04 DBMET02070 | ||
| 0.079 | 0.012 | 0.082 | Beta 2 adrenoreceptor antagonist | 0.081 0.011 DBMET02068 0.082 0.011 DBMET02069 0.082 0.011 DBMET02070 | DBMET02070 | |
| 0.11 | 0.044 | 0.144 | Uric acid excretion stimulant | 0.144 0.025 DBMET02068 0.136 0.029 DBMET02069 0.136 0.029 DBMET02070 | DBMET02068 | |
| 0.077 | 0.01 | 0.108 | Vanilloid 2 antagonist | 0.099 0.005 DBMET02068 0.108 0.005 DBMET02069 0.108 0.005 DBMET02070 | DBMET02070 | |
| 0.07 | 0.004 | 0.07 | Vanilloid 3 antagonist | 0.062 0.005 DBMET02068 0.068 0.004 DBMET02069 0.068 0.004 DBMET02070 | ||
| 0.076 | 0.01 | 0.076 | Mannosidase inhibitor | 0.064 0.014 DBMET02068 0.057 0.019 DBMET02069 0.057 0.019 DBMET02070 | ||
| 0.074 | 0.009 | 0.074 | Estrogen-related receptor alpha antagonist | 0.039 0.018 DBMET02068 0.052 0.013 DBMET02069 0.052 0.013 DBMET02070 | ||
| 0.083 | 0.017 | 0.088 | Enoyl-[acyl-carrier-protein] reductase inhibitor | 0.088 0.015 DBMET02068 0.08 0.019 DBMET02069 0.08 0.019 DBMET02070 | DBMET02068 | |
| 0.069 | 0.005 | 0.069 | Guanylate cyclase inhibitor | 0.066 0.007 DBMET02068 0.063 0.009 DBMET02069 0.063 0.009 DBMET02070 | ||
| 0.076 | 0.012 | 0.076 | Beta 2 adrenoreceptor agonist | 0.076 0.012 DBMET02068 0.074 0.014 DBMET02069 0.074 0.014 DBMET02070 | ||
| 0.095 | 0.031 | 0.095 | Opioid delta receptor antagonist | |||
| 0.098 | 0.034 | 0.098 | Cathepsin G inhibitor | 0.088 0.039 DBMET02068 0.077 0.046 DBMET02069 0.077 0.046 DBMET02070 | ||
| 0.085 | 0.023 | 0.101 | Maillard reaction inhibitor | 0.101 0.016 DBMET02068 0.096 0.018 DBMET02069 0.096 0.018 DBMET02070 | DBMET02068 | |
| 0.072 | 0.009 | 0.072 | Phosphoglycerate kinase inhibitor | 0.067 0.01 DBMET02068 0.069 0.01 DBMET02069 0.069 0.01 DBMET02070 | ||
| 0.133 | 0.07 | 0.133 | Nav1.2 sodium channel blocker | |||
| 0.076 | 0.013 | 0.083 | Dihydroorotate oxidase inhibitor | 0.083 0.009 DBMET02068 0.075 0.013 DBMET02069 0.075 0.013 DBMET02070 | DBMET02068 | |
| 0.131 | 0.068 | 0.139 | M17 leucyl aminopeptidase inhibitor | 0.135 0.066 DBMET02068 0.139 0.063 DBMET02069 0.139 0.063 DBMET02070 | DBMET02070 | |
| 0.085 | 0.023 | 0.085 | Argininosuccinate synthase inhibitor | 0.073 0.029 DBMET02068 0.063 0.035 DBMET02069 0.063 0.035 DBMET02070 | ||
| 0.139 | 0.077 | 0.149 | Activin receptor-like kinase 2 inhibitor | 0.14 0.076 DBMET02068 0.149 0.067 DBMET02069 0.149 0.067 DBMET02070 | DBMET02070 | |
| 0.072 | 0.011 | 0.072 | Alpha 1L adrenoreceptor antagonist | 0.065 0.017 DBMET02068 0.058 0.024 DBMET02069 0.058 0.024 DBMET02070 | ||
| 0.066 | 0.005 | 0.066 | Estradiol 17 beta-dehydrogenase 1 inhibitor | 0.06 0.005 DBMET02068 0.053 0.006 DBMET02069 0.053 0.006 DBMET02070 | ||
| 0.101 | 0.04 | 0.101 | Interleukin 5 antagonist | |||
| 0.075 | 0.014 | 0.089 | Carbonic anhydrase VII inhibitor | 0.086 0.011 DBMET02068 0.089 0.011 DBMET02069 0.089 0.011 DBMET02070 | DBMET02070 | |
| 0.135 | 0.075 | 0.147 | Cytokine production inhibitor | 0.147 0.065 DBMET02068 0.145 0.066 DBMET02069 0.145 0.066 DBMET02070 | DBMET02068 | |
| 0.07 | 0.011 | 0.07 | Immunoglobulin Fc receptor antagonist | 0.061 0.022 DBMET02068 0.059 0.026 DBMET02069 0.059 0.026 DBMET02070 | ||
| 0.1 | 0.04 | 0.1 | Bromodomain-containing protein 2 inhibitor | 0.091 0.054 DBMET02068 0.082 0.072 DBMET02069 0.082 0.072 DBMET02070 | ||
| 0.093 | 0.036 | 0.093 | Metalloproteinase-9 inhibitor | 0.091 0.037 DBMET02068 0.08 0.044 DBMET02069 0.08 0.044 DBMET02070 | ||
| 0.086 | 0.028 | 0.097 | Leukotriene antagonist | 0.097 0.023 DBMET02068 0.092 0.025 DBMET02069 0.092 0.025 DBMET02070 | DBMET02068 | |
| 0.141 | 0.084 | 0.151 | Insulin secretagoues | 0.151 0.073 DBMET02068 0.142 0.083 DBMET02069 0.142 0.083 DBMET02070 | DBMET02068 | |
| 0.143 | 0.086 | 0.149 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | 0.149 0.073 DBMET02068 0.143 0.086 DBMET02069 0.143 0.086 DBMET02070 | DBMET02068 | |
| 0.062 | 0.006 | 0.062 | Kainate receptor agonist | 0.057 0.008 DBMET02068 0.053 0.011 DBMET02069 0.053 0.011 DBMET02070 | ||
| 0.062 | 0.006 | 0.062 | Glutamate (mGluR8) agonist | 0.062 0.006 DBMET02068 0.059 0.007 DBMET02069 0.059 0.007 DBMET02070 | ||
| 0.07 | 0.014 | 0.071 | Lysophosphatidic acid 3 receptor antagonist | 0.071 0.014 DBMET02068 0.069 0.015 DBMET02069 0.069 0.015 DBMET02070 | DBMET02068 | |
| 0.137 | 0.081 | 0.137 | MAP3K9 inhibitor | |||
| 0.09 | 0.035 | 0.09 | Opioid mu receptor antagonist | |||
| 0.07 | 0.015 | 0.073 | Adenine nucleotide translocase inhibitor | 0.073 0.013 DBMET02068 0.072 0.013 DBMET02069 0.072 0.013 DBMET02070 | DBMET02068 | |
| 0.064 | 0.009 | 0.064 | Inosine monophosphate dehydrogenase inhibitor | 0.048 0.016 DBMET02068 0.042 0.02 DBMET02069 0.042 0.02 DBMET02070 | ||
| 0.071 | 0.017 | 0.071 | Epithelial sodium channel blocker | 0.061 0.028 DBMET02068 0.055 0.037 DBMET02069 0.055 0.037 DBMET02070 | ||
| 0.07 | 0.016 | 0.07 | NMDA receptor subunit 3B antagonist | 0.045 0.029 DBMET02068 0.039 0.037 DBMET02069 0.039 0.037 DBMET02070 | ||
| 0.127 | 0.073 | 0.144 | Cyclooxygenase 2 inhibitor | 0.144 0.058 DBMET02068 0.136 0.065 DBMET02069 0.136 0.065 DBMET02070 | DBMET02068 | |
| 0.079 | 0.026 | 0.079 | NMDA 2C receptor antagonist | 0.057 0.05 DBMET02068 | ||
| 0.072 | 0.019 | 0.085 | Leukotriene B4 antagonist | 0.085 0.014 DBMET02068 0.085 0.014 DBMET02069 0.085 0.014 DBMET02070 | DBMET02070 | |
| 0.058 | 0.005 | 0.058 | Sodium/glucose cotransporter 2 inhibitor | 0.052 0.006 DBMET02068 0.044 0.008 DBMET02069 0.044 0.008 DBMET02070 | ||
| 0.211 | 0.157 | 0.414 | Angiogenesis inhibitor | 0.37 0.063 DBMET02068 0.414 0.049 DBMET02069 0.414 0.049 DBMET02070 | DBMET02070 | |
| 0.067 | 0.014 | 0.067 | Heparanase inhibitor | 0.063 0.018 DBMET02068 0.061 0.022 DBMET02069 0.061 0.022 DBMET02070 | ||
| 0.058 | 0.006 | 0.058 | Uridine phosphorylase inhibitor | 0.055 0.007 DBMET02068 0.048 0.009 DBMET02069 0.048 0.009 DBMET02070 | ||
| 0.138 | 0.086 | 0.138 | Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor | |||
| 0.094 | 0.042 | 0.108 | Inducible nitric-oxide synthase inhibitor | 0.108 0.031 DBMET02068 0.106 0.032 DBMET02069 0.106 0.032 DBMET02070 | DBMET02068 | |
| 0.054 | 0.003 | 0.054 | Estrogen-related receptor gamma antagonist | 0.044 0.004 DBMET02068 0.042 0.005 DBMET02069 0.042 0.005 DBMET02070 | ||
| 0.065 | 0.014 | 0.065 | Factor III inhibitor | 0.057 0.021 DBMET02068 0.061 0.017 DBMET02069 0.061 0.017 DBMET02070 | ||
| 0.061 | 0.01 | 0.061 | Fumarate hydratase inhibitor | 0.053 0.012 DBMET02068 0.046 0.015 DBMET02069 0.046 0.015 DBMET02070 | ||
| 0.09 | 0.039 | 0.09 | Interferon agonist | 0.082 0.05 DBMET02068 0.073 0.065 DBMET02069 0.073 0.065 DBMET02070 | ||
| 0.056 | 0.006 | 0.056 | Melatonin receptor 1A agonist | 0.049 0.008 DBMET02068 0.043 0.011 DBMET02069 0.043 0.011 DBMET02070 | ||
| 0.067 | 0.017 | 0.07 | CD45 antagonist | 0.07 0.015 DBMET02068 0.063 0.019 DBMET02069 0.063 0.019 DBMET02070 | DBMET02068 | |
| 0.058 | 0.008 | 0.062 | Melatonin 2 agonist | 0.059 0.008 DBMET02068 0.062 0.007 DBMET02069 0.062 0.007 DBMET02070 | DBMET02070 | |
| 0.072 | 0.023 | 0.08 | Sphingosine kinase inhibitor | 0.08 0.016 DBMET02068 0.075 0.02 DBMET02069 0.075 0.02 DBMET02070 | DBMET02068 | |
| 0.086 | 0.038 | 0.112 | Histone deacetylase SIRT1 stimulant | 0.112 0.021 DBMET02068 0.112 0.021 DBMET02069 0.112 0.021 DBMET02070 | DBMET02070 | |
| 0.086 | 0.038 | 0.112 | Histone deacetylase stimulant | 0.112 0.021 DBMET02068 0.112 0.021 DBMET02069 0.112 0.021 DBMET02070 | DBMET02070 | |
| 0.087 | 0.039 | 0.087 | NMDA 2 receptor antagonist | |||
| 0.057 | 0.009 | 0.057 | Glutamate (mGluR3) antagonist | 0.049 0.013 DBMET02068 0.043 0.018 DBMET02069 0.043 0.018 DBMET02070 | ||
| 0.078 | 0.03 | 0.078 | NMDA receptor glycine site agonist | 0.065 0.041 DBMET02068 | ||
| 0.052 | 0.004 | 0.052 | Glutamate (mGluR3) agonist | 0.044 0.007 DBMET02068 0.044 0.007 DBMET02069 0.044 0.007 DBMET02070 | ||
| 0.073 | 0.026 | 0.076 | Phosphodiesterase 1C inhibitor | 0.074 0.025 DBMET02068 0.076 0.023 DBMET02069 0.076 0.023 DBMET02070 | DBMET02070 | |
| 0.128 | 0.08 | 0.128 | CC chemokine 6 receptor antagonist | 0.12 0.117 DBMET02068 0.12 0.116 DBMET02069 0.12 0.116 DBMET02070 | ||
| 0.112 | 0.066 | 0.113 | Nav1.5 sodium channel blocker | 0.113 0.064 DBMET02068 0.103 0.08 DBMET02069 0.103 0.08 DBMET02070 | DBMET02068 | |
| 0.059 | 0.013 | 0.059 | Liver X receptor alpha agonist | 0.057 0.014 DBMET02068 0.054 0.016 DBMET02069 0.054 0.016 DBMET02070 | ||
| 0.078 | 0.033 | 0.078 | Protein kinase C beta inhibitor | 0.072 0.043 DBMET02068 0.065 0.059 DBMET02069 0.065 0.059 DBMET02070 | ||
| 0.072 | 0.028 | 0.072 | Phosphodiesterase 1B inhibitor | 0.066 0.034 DBMET02068 0.07 0.03 DBMET02069 0.07 0.03 DBMET02070 | ||
| 0.064 | 0.021 | 0.065 | Leukotriene C antagonist | 0.065 0.019 DBMET02068 0.062 0.024 DBMET02069 0.062 0.024 DBMET02070 | DBMET02068 | |
| 0.08 | 0.037 | 0.123 | Dopamine agonist | 0.123 0.019 DBMET02068 0.112 0.023 DBMET02069 0.112 0.023 DBMET02070 | DBMET02068 | |
| 0.08 | 0.037 | 0.083 | Amidase inhibitor | 0.083 0.035 DBMET02068 0.075 0.042 DBMET02069 0.075 0.042 DBMET02070 | DBMET02068 | |
| 0.057 | 0.016 | 0.057 | Geranyltranstransferase inhibitor | 0.049 0.023 DBMET02068 0.042 0.033 DBMET02069 0.042 0.033 DBMET02070 | ||
| 0.079 | 0.037 | 0.079 | Phospholipase D inhibitor | 0.067 0.061 DBMET02068 | ||
| 0.093 | 0.051 | 0.093 | NMDA receptor antagonist | |||
| 0.065 | 0.023 | 0.065 | Glycine transporter 2 inhibitor | |||
| 0.135 | 0.094 | 0.135 | MAP kinase 3 inhibitor | 0.134 0.096 DBMET02068 0.128 0.111 DBMET02069 0.128 0.111 DBMET02070 | ||
| 0.082 | 0.041 | 0.082 | Adenosine A3 receptor antagonist | 0.073 0.054 DBMET02068 | ||
| 0.143 | 0.103 | 0.143 | Antipruritic | |||
| 0.089 | 0.049 | 0.13 | Platelet growth factor antagonist | 0.092 0.046 DBMET02068 0.13 0.025 DBMET02069 0.13 0.025 DBMET02070 | DBMET02070 | |
| 0.058 | 0.018 | 0.058 | Oxytocin agonist | 0.046 0.027 DBMET02068 0.04 0.031 DBMET02069 0.04 0.031 DBMET02070 | ||
| 0.049 | 0.009 | 0.049 | CF transmembrane conductance regulator antagonist | 0.046 0.012 DBMET02068 0.043 0.018 DBMET02069 0.043 0.018 DBMET02070 | ||
| 0.044 | 0.004 | 0.044 | Hedgehog signaling activator | 0.041 0.004 DBMET02068 0.038 0.005 DBMET02069 0.038 0.005 DBMET02070 | ||
| 0.058 | 0.018 | 0.058 | Fructose-1,6-bisphosphatase inhibitor | 0.051 0.024 DBMET02068 0.055 0.02 DBMET02069 0.055 0.02 DBMET02070 | ||
| 0.116 | 0.078 | 0.116 | MAP kinase kinase inhibitor | |||
| 0.047 | 0.009 | 0.048 | ATP citrate lysase inhibitor | 0.048 0.008 DBMET02068 0.043 0.011 DBMET02069 0.043 0.011 DBMET02070 | DBMET02068 | |
| 0.075 | 0.037 | 0.1 | Fibroblast growth factor 2 antagonist | 0.09 0.028 DBMET02068 0.1 0.024 DBMET02069 0.1 0.024 DBMET02070 | DBMET02070 | |
| 0.06 | 0.022 | 0.06 | CXC chemokine 1 receptor antagonist | 0.055 0.029 DBMET02068 0.049 0.039 DBMET02069 0.049 0.039 DBMET02070 | ||
| 0.044 | 0.006 | 0.044 | Sodium/glucose cotransporter inhibitor | 0.04 0.007 DBMET02068 0.034 0.009 DBMET02069 0.034 0.009 DBMET02070 | ||
| 0.052 | 0.015 | 0.052 | Beta adrenoreceptor agonist | 0.051 0.016 DBMET02068 0.049 0.019 DBMET02069 0.049 0.019 DBMET02070 | ||
| 0.082 | 0.045 | 0.082 | Analgesic, opioid | |||
| 0.076 | 0.039 | 0.096 | Phosphodiesterase III inhibitor | 0.075 0.039 DBMET02068 0.096 0.024 DBMET02069 0.096 0.024 DBMET02070 | DBMET02070 | |
| 0.077 | 0.04 | 0.077 | Secretase beta inhibitor | 0.073 0.045 DBMET02068 0.065 0.06 DBMET02069 0.065 0.06 DBMET02070 | ||
| 0.083 | 0.047 | 0.091 | Alpha 2a adrenoreceptor antagonist | 0.085 0.045 DBMET02068 0.091 0.041 DBMET02069 0.091 0.041 DBMET02070 | DBMET02070 | |
| 0.051 | 0.015 | 0.051 | GABA uptake inhibitor | 0.05 0.016 DBMET02068 0.044 0.021 DBMET02069 0.044 0.021 DBMET02070 | ||
| 0.088 | 0.052 | 0.096 | Antineoplastic antibiotic | 0.096 0.048 DBMET02068 0.089 0.052 DBMET02069 0.089 0.052 DBMET02070 | DBMET02068 | |
| 0.063 | 0.028 | 0.063 | Glucosylceramidase inhibitor | 0.061 0.029 DBMET02068 0.055 0.038 DBMET02069 0.055 0.038 DBMET02070 | ||
| 0.054 | 0.019 | 0.054 | Purinergic P2X4 antagonist | 0.049 0.027 DBMET02068 0.043 0.038 DBMET02069 0.043 0.038 DBMET02070 | ||
| 0.07 | 0.035 | 0.07 | 5 Hydroxytryptamine 3 agonist | |||
| 0.056 | 0.021 | 0.06 | Dopamine D5 antagonist | 0.06 0.019 DBMET02068 0.057 0.021 DBMET02069 0.057 0.021 DBMET02070 | DBMET02068 | |
| 0.071 | 0.037 | 0.098 | CDC25B inhibitor | 0.098 0.017 DBMET02068 0.089 0.021 DBMET02069 0.089 0.021 DBMET02070 | DBMET02068 | |
| 0.07 | 0.035 | 0.07 | Interferon inducer | 0.061 0.05 DBMET02068 | ||
| 0.051 | 0.017 | 0.056 | Dihydrofolate reductase inhibitor | 0.053 0.016 DBMET02068 0.056 0.013 DBMET02069 0.056 0.013 DBMET02070 | DBMET02070 | |
| 0.039 | 0.005 | 0.039 | Inosine monophosphate dehydrogenase 2 inhibitor | 0.027 0.009 DBMET02068 0.023 0.011 DBMET02069 0.023 0.011 DBMET02070 | ||
| 0.088 | 0.054 | 0.088 | Transcription factor NF kappa B stimulant | 0.085 0.06 DBMET02068 | ||
| 0.064 | 0.03 | 0.076 | Fatty acid synthase inhibitor | 0.076 0.021 DBMET02068 0.068 0.027 DBMET02069 0.068 0.027 DBMET02070 | DBMET02068 | |
| 0.075 | 0.041 | 0.075 | Alpha adrenoreceptor agonist | 0.066 0.05 DBMET02068 0.067 0.048 DBMET02069 0.067 0.048 DBMET02070 | ||
| 0.049 | 0.015 | 0.049 | Heme oxygenase inhibitor | 0.047 0.018 DBMET02068 0.045 0.022 DBMET02069 0.045 0.022 DBMET02070 | ||
| 0.057 | 0.024 | 0.057 | Adenosine deaminase inhibitor | 0.056 0.025 DBMET02068 0.049 0.031 DBMET02069 0.049 0.031 DBMET02070 | ||
| 0.075 | 0.042 | 0.075 | Peroxisome proliferator-activated receptor gamma antagonist | 0.073 0.047 DBMET02068 0.07 0.054 DBMET02069 0.07 0.054 DBMET02070 | ||
| 0.045 | 0.012 | 0.045 | Free fatty acid receptor 1 antagonist | 0.044 0.012 DBMET02068 0.043 0.014 DBMET02069 0.043 0.014 DBMET02070 | ||
| 0.078 | 0.045 | 0.159 | CDC25A inhibitor | 0.159 0.011 DBMET02068 0.144 0.014 DBMET02069 0.144 0.014 DBMET02070 | DBMET02068 | |
| 0.052 | 0.019 | 0.052 | NMDA receptor subunit 3A antagonist | |||
| 0.044 | 0.012 | 0.045 | Melatonin 1 agonist | 0.045 0.012 DBMET02068 0.042 0.014 DBMET02069 0.042 0.014 DBMET02070 | DBMET02068 | |
| 0.082 | 0.05 | 0.082 | Metalloproteinase-2 inhibitor | 0.081 0.051 DBMET02068 0.075 0.058 DBMET02069 0.075 0.058 DBMET02070 | ||
| 0.065 | 0.033 | 0.065 | Potassium channel intermediate-conductance Ca-activated blocker | 0.057 0.048 DBMET02068 | ||
| 0.089 | 0.057 | 0.098 | Alpha 2 adrenoreceptor antagonist | 0.091 0.054 DBMET02068 0.098 0.049 DBMET02069 0.098 0.049 DBMET02070 | DBMET02070 | |
| 0.051 | 0.019 | 0.051 | Glutamate (mGluR group III) antagonist | 0.045 0.027 DBMET02068 | ||
| 0.069 | 0.038 | 0.069 | Protease 3C (Human rhinovirus) inhibitor | 0.063 0.047 DBMET02068 0.058 0.056 DBMET02069 0.058 0.056 DBMET02070 | ||
| 0.057 | 0.025 | 0.057 | Opioid mu receptor agonist | |||
| 0.064 | 0.033 | 0.064 | Sphingosine 1-phosphate receptor 3 antagonist | 0.055 0.047 DBMET02068 | ||
| 0.034 | 0.003 | 0.034 | Antibiotic Anthracycline-like | 0.03 0.004 DBMET02068 0.028 0.004 DBMET02069 0.028 0.004 DBMET02070 | ||
| 0.049 | 0.018 | 0.059 | DNA gyrase subunit A inhibitor | 0.059 0.01 DBMET02068 0.052 0.015 DBMET02069 0.052 0.015 DBMET02070 | DBMET02068 | |
| 0.044 | 0.012 | 0.044 | Melatonin agonist | 0.043 0.013 DBMET02068 0.041 0.014 DBMET02069 0.041 0.014 DBMET02070 | ||
| 0.113 | 0.082 | 0.113 | Nav1.3 sodium channel blocker | |||
| 0.07 | 0.039 | 0.071 | MDM2 inhibitor | 0.071 0.035 DBMET02068 0.067 0.048 DBMET02069 0.067 0.048 DBMET02070 | DBMET02068 | |
| 0.043 | 0.012 | 0.043 | Carnitine palmitoyltransferase 1 inhibitor | 0.039 0.017 DBMET02068 0.035 0.021 DBMET02069 0.035 0.021 DBMET02070 | ||
| 0.042 | 0.011 | 0.042 | Liver X receptor beta antagonist | 0.026 0.023 DBMET02068 | ||
| 0.043 | 0.013 | 0.043 | Carnitine palmitoyltransferase inhibitor | 0.038 0.018 DBMET02068 0.035 0.022 DBMET02069 0.035 0.022 DBMET02070 | ||
| 0.096 | 0.065 | 0.133 | Butyrylcholinesterase inhibitor | 0.112 0.052 DBMET02068 0.133 0.041 DBMET02069 0.133 0.041 DBMET02070 | DBMET02070 | |
| 0.037 | 0.007 | 0.037 | Thyroid hormone agonist | 0.034 0.009 DBMET02068 0.031 0.012 DBMET02069 0.031 0.012 DBMET02070 | ||
| 0.054 | 0.024 | 0.061 | Cholesterol esterase inhibitor | 0.061 0.016 DBMET02068 0.058 0.02 DBMET02069 0.058 0.02 DBMET02070 | DBMET02068 | |
| 0.06 | 0.031 | 0.06 | Matrix metalloproteinase 1 inhibitor | 0.056 0.035 DBMET02068 0.045 0.042 DBMET02069 0.045 0.042 DBMET02070 | ||
| 0.056 | 0.027 | 0.103 | Plasminogen activator inhibitor antagonist | 0.092 0.012 DBMET02068 0.103 0.01 DBMET02069 0.103 0.01 DBMET02070 | DBMET02070 | |
| 0.098 | 0.069 | 0.098 | Nav1.1 sodium channel blocker | |||
| 0.065 | 0.036 | 0.065 | Collagenase 3 inhibitor | 0.056 0.047 DBMET02068 | ||
| 0.102 | 0.074 | 0.102 | GABA receptor agonist | |||
| 0.046 | 0.018 | 0.046 | Diamine oxidase inhibitor | 0.039 0.025 DBMET02068 0.038 0.025 DBMET02069 0.038 0.025 DBMET02070 | ||
| 0.04 | 0.013 | 0.041 | Cholesterol ester transfer protein antagonist | 0.041 0.012 DBMET02068 0.036 0.016 DBMET02069 0.036 0.016 DBMET02070 | DBMET02068 | |
| 0.044 | 0.017 | 0.044 | Nicotinic acid receptor agonist | |||
| 0.066 | 0.039 | 0.066 | NMDA receptor agonist | |||
| 0.064 | 0.037 | 0.064 | Alpha 2 adrenoreceptor agonist | 0.057 0.046 DBMET02068 0.057 0.047 DBMET02069 0.057 0.047 DBMET02070 | ||
| 0.052 | 0.025 | 0.069 | Dopamine D2 agonist | 0.069 0.017 DBMET02068 0.063 0.019 DBMET02069 0.063 0.019 DBMET02070 | DBMET02068 | |
| 0.031 | 0.005 | 0.031 | Ileal bile acid transport inhibitor | 0.026 0.006 DBMET02068 0.026 0.006 DBMET02069 0.026 0.006 DBMET02070 | ||
| 0.036 | 0.01 | 0.036 | Purinergic P2Y15 antagonist | 0.033 0.012 DBMET02068 0.032 0.013 DBMET02069 0.032 0.013 DBMET02070 | ||
| 0.05 | 0.024 | 0.05 | Glutamate (mGluR group III) agonist | 0.046 0.027 DBMET02068 0.044 0.028 DBMET02069 0.044 0.028 DBMET02070 | ||
| 0.036 | 0.01 | 0.036 | Dopamine autoreceptor agonist | |||
| 0.033 | 0.007 | 0.033 | Prostaglandin F2 alpha agonist | 0.032 0.008 DBMET02068 0.028 0.01 DBMET02069 0.028 0.01 DBMET02070 | ||
| 0.137 | 0.112 | 0.137 | LIM domain kinase 1 inhibitor | |||
| 0.039 | 0.014 | 0.134 | Catechol O-methyltransferase inhibitor | 0.134 0.004 DBMET02068 0.125 0.004 DBMET02069 0.125 0.004 DBMET02070 | DBMET02068 | |
| 0.05 | 0.025 | 0.059 | Phosphodiesterase 3B inhibitor | 0.049 0.026 DBMET02068 0.059 0.02 DBMET02069 0.059 0.02 DBMET02070 | DBMET02070 | |
| 0.047 | 0.023 | 0.047 | GABA B receptor antagonist | 0.047 0.023 DBMET02068 0.042 0.031 DBMET02069 0.042 0.031 DBMET02070 | ||
| 0.058 | 0.033 | 0.058 | NMDA 2B receptor antagonist | |||
| 0.107 | 0.082 | 0.107 | Acetylcholine muscarinic antagonist | |||
| 0.029 | 0.005 | 0.029 | NMDA receptor phencyclidine site antagonist | 0.017 0.009 DBMET02068 0.014 0.012 DBMET02069 0.014 0.012 DBMET02070 | ||
| 0.051 | 0.027 | 0.051 | Cytokine production stimulant | 0.046 0.04 DBMET02068 | ||
| 0.057 | 0.033 | 0.059 | DNA helicase inhibitor | 0.056 0.034 DBMET02068 0.059 0.029 DBMET02069 0.059 0.029 DBMET02070 | DBMET02070 | |
| 0.071 | 0.047 | 0.084 | ZAP-70 protein tyrosine kinase inhibitor | 0.079 0.037 DBMET02068 0.084 0.03 DBMET02069 0.084 0.03 DBMET02070 | DBMET02070 | |
| 0.032 | 0.008 | 0.032 | Vanilloid 2 agonist | 0.029 0.01 DBMET02068 0.027 0.014 DBMET02069 0.027 0.014 DBMET02070 | ||
| 0.028 | 0.004 | 0.028 | Estrogen-related receptor gamma agonist | 0.024 0.006 DBMET02068 0.021 0.009 DBMET02069 0.021 0.009 DBMET02070 | ||
| 0.069 | 0.045 | 0.069 | Matrix metalloproteinase inhibitor | 0.064 0.049 DBMET02068 | ||
| 0.048 | 0.025 | 0.048 | AICAR transformylase inhibitor | |||
| 0.074 | 0.051 | 0.074 | Potassium channel (Tandem pore domain) blocker | 0.07 0.064 DBMET02068 | ||
| 0.038 | 0.015 | 0.038 | HCV NS5B polymerase inhibitor | |||
| 0.06 | 0.037 | 0.063 | Botulinum neurotoxin type A inhibitor | 0.063 0.033 DBMET02068 0.058 0.041 DBMET02069 0.058 0.041 DBMET02070 | DBMET02068 | |
| 0.06 | 0.037 | 0.06 | Alpha 1 adrenoreceptor agonist | 0.054 0.044 DBMET02068 0.056 0.041 DBMET02069 0.056 0.041 DBMET02070 | ||
| 0.056 | 0.033 | 0.056 | NMDA 2A receptor antagonist | |||
| 0.037 | 0.014 | 0.046 | Lysophosphatidic acid 2 receptor antagonist | 0.044 0.01 DBMET02068 0.046 0.01 DBMET02069 0.046 0.01 DBMET02070 | DBMET02070 | |
| 0.045 | 0.022 | 0.045 | Plasmepsin II inhibitor | 0.043 0.025 DBMET02068 0.041 0.029 DBMET02069 0.041 0.029 DBMET02070 | ||
| 0.062 | 0.04 | 0.062 | Heme oxygenase stimulant | 0.059 0.05 DBMET02068 | ||
| 0.063 | 0.04 | 0.063 | 5 Hydroxytryptamine 5A antagonist | |||
| 0.036 | 0.014 | 0.036 | Nicotinic alpha3beta4 receptor agonist | 0.032 0.018 DBMET02068 0.028 0.025 DBMET02069 0.028 0.025 DBMET02070 | ||
| 0.044 | 0.022 | 0.044 | Urate transporter 1 inhibitor | 0.035 0.033 DBMET02068 | ||
| 0.05 | 0.028 | 0.05 | CC chemokine 4 receptor antagonist | 0.046 0.035 DBMET02068 0.047 0.033 DBMET02069 0.047 0.033 DBMET02070 | ||
| 0.076 | 0.055 | 0.076 | Nicotinic alpha4beta2 receptor antagonist | 0.068 0.065 DBMET02068 | ||
| 0.071 | 0.05 | 0.071 | Calcium channel L-type blocker | 0.067 0.057 DBMET02068 0.068 0.055 DBMET02069 0.068 0.055 DBMET02070 | ||
| 0.19 | 0.169 | 0.256 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.253 0.103 DBMET02068 0.256 0.101 DBMET02069 0.256 0.101 DBMET02070 | DBMET02070 | |
| 0.087 | 0.067 | 0.087 | Polo-like kinase-1 inhibitor | 0.085 0.072 DBMET02068 0.087 0.067 DBMET02069 0.087 0.067 DBMET02070 | ||
| 0.042 | 0.021 | 0.042 | 5 Hydroxytryptamine 2B agonist | 0.036 0.034 DBMET02068 | ||
| 0.052 | 0.031 | 0.052 | Potassium channel (Inward rectifier) activator | 0.049 0.037 DBMET02068 | ||
| 0.039 | 0.018 | 0.039 | Ceramide glucosyltransferase inhibitor | 0.036 0.025 DBMET02068 | ||
| 0.041 | 0.02 | 0.041 | Delayed rectifier potassium channel blocker | |||
| 0.045 | 0.025 | 0.047 | Nerve growth factor antagonist | 0.047 0.023 DBMET02068 0.042 0.032 DBMET02069 0.042 0.032 DBMET02070 | DBMET02068 | |
| 0.058 | 0.039 | 0.058 | 5 Hydroxytryptamine 5 antagonist | |||
| 0.098 | 0.078 | 0.109 | Protein kinase (CK2) alpha inhibitor | 0.109 0.069 DBMET02068 0.109 0.069 DBMET02069 0.109 0.069 DBMET02070 | DBMET02070 | |
| 0.054 | 0.035 | 0.054 | Nicotinic alpha3beta2 receptor antagonist | |||
| 0.041 | 0.022 | 0.041 | Leukotriene C4 antagonist | 0.041 0.022 DBMET02068 0.039 0.027 DBMET02069 0.039 0.027 DBMET02070 | ||
| 0.049 | 0.03 | 0.049 | Benzodiazepine antagonist | 0.047 0.034 DBMET02068 0.044 0.042 DBMET02069 0.044 0.042 DBMET02070 | ||
| 0.024 | 0.005 | 0.024 | Nicotinic acid receptor 1 antagonist | 0.016 0.014 DBMET02068 | ||
| 0.027 | 0.008 | 0.027 | Isoleucine-tRNA ligase inhibitor | 0.026 0.009 DBMET02068 0.025 0.01 DBMET02069 0.025 0.01 DBMET02070 | ||
| 0.033 | 0.014 | 0.033 | Thiazolidinedione | 0.03 0.019 DBMET02068 0.029 0.02 DBMET02069 0.029 0.02 DBMET02070 | ||
| 0.049 | 0.031 | 0.049 | Potassium channel (ATP-sensitive) activator | 0.047 0.037 DBMET02068 | ||
| 0.054 | 0.036 | 0.054 | Ornithine carbamoyltransferase inhibitor | 0.047 0.042 DBMET02068 | ||
| 0.038 | 0.02 | 0.038 | RNA-directed RNA polymerase inhibitor | |||
| 0.077 | 0.06 | 0.088 | Phosphodiesterase 3A inhibitor | 0.088 0.045 DBMET02069 0.088 0.045 DBMET02070 | DBMET02070 | |
| 0.065 | 0.049 | 0.071 | Phosphodiesterase 4B inhibitor | 0.071 0.043 DBMET02069 0.071 0.043 DBMET02070 | DBMET02070 | |
| 0.063 | 0.047 | 0.063 | Neutrophil collagenase inhibitor | 0.061 0.049 DBMET02068 | ||
| 0.059 | 0.042 | 0.059 | Acetylcholine M3 receptor antagonist | |||
| 0.03 | 0.013 | 0.03 | Nicotinic acid receptor 2 antagonist | |||
| 0.06 | 0.043 | 0.06 | TRPA1 antagonist | |||
| 0.05 | 0.034 | 0.05 | Bombesin 2 receptor antagonist | 0.045 0.042 DBMET02068 0.046 0.039 DBMET02069 0.046 0.039 DBMET02070 | ||
| 0.028 | 0.012 | 0.028 | Complement factor 1s inhibitor | 0.025 0.018 DBMET02068 | ||
| 0.051 | 0.036 | 0.051 | 5 Hydroxytryptamine 4 antagonist | 0.047 0.045 DBMET02068 | ||
| 0.035 | 0.019 | 0.035 | Protein kinase (CK2) beta inhibitor | 0.035 0.019 DBMET02068 0.032 0.028 DBMET02069 0.032 0.028 DBMET02070 | ||
| 0.027 | 0.011 | 0.027 | Fructose-1,6-bisphosphatase 1 inhibitor | 0.026 0.013 DBMET02068 0.026 0.013 DBMET02069 0.026 0.013 DBMET02070 | ||
| 0.052 | 0.036 | 0.052 | 5 Hydroxytryptamine 2 agonist | |||
| 0.06 | 0.045 | 0.06 | Corticotropin releasing factor 2 receptor antagonist | 0.059 0.048 DBMET02068 | ||
| 0.049 | 0.034 | 0.049 | Metalloproteinase-3 inhibitor | |||
| 0.039 | 0.024 | 0.039 | Farnesoid X receptor agonist | 0.038 0.026 DBMET02068 | ||
| 0.019 | 0.004 | 0.024 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | 0.024 0.003 DBMET02068 0.023 0.004 DBMET02069 0.023 0.004 DBMET02070 | DBMET02068 | |
| 0.058 | 0.043 | 0.058 | Carbonic anhydrase stimulant | 0.055 0.047 DBMET02068 0.056 0.045 DBMET02069 0.056 0.045 DBMET02070 | ||
| 0.026 | 0.011 | 0.026 | Glutamate (mGluR1a) agonist | 0.022 0.015 DBMET02068 | ||
| 0.021 | 0.007 | 0.021 | Telomerase stimulant | 0.02 0.008 DBMET02068 0.018 0.01 DBMET02069 0.018 0.01 DBMET02070 | ||
| 0.042 | 0.028 | 0.048 | Sphingosine kinase 1 inhibitor | 0.048 0.018 DBMET02068 0.044 0.024 DBMET02069 0.044 0.024 DBMET02070 | DBMET02068 | |
| 0.045 | 0.031 | 0.048 | Dihydroorotase inhibitor | 0.048 0.027 DBMET02068 0.041 0.036 DBMET02069 0.041 0.036 DBMET02070 | DBMET02068 | |
| 0.053 | 0.039 | 0.053 | Lysine-specific demethylase 1A inhibitor | 0.053 0.039 DBMET02068 0.049 0.047 DBMET02069 0.049 0.047 DBMET02070 | ||
| 0.036 | 0.022 | 0.036 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | |||
| 0.088 | 0.074 | 0.091 | Toll-Like receptor 3 antagonist | 0.091 0.066 DBMET02069 0.091 0.066 DBMET02070 | DBMET02070 | |
| 0.026 | 0.013 | 0.026 | CYP24 inhibitor | 0.026 0.013 DBMET02068 0.025 0.014 DBMET02069 0.025 0.014 DBMET02070 | ||
| 0.031 | 0.017 | 0.031 | Liver X receptor alpha antagonist | 0.027 0.024 DBMET02068 | ||
| 0.05 | 0.037 | 0.05 | Dihydroorotate dehydrogenase inhibitor | 0.048 0.039 DBMET02068 | ||
| 0.04 | 0.027 | 0.044 | Dopamine D3 agonist | 0.044 0.024 DBMET02068 0.035 0.033 DBMET02069 0.035 0.033 DBMET02070 | DBMET02068 | |
| 0.069 | 0.056 | 0.091 | Lipase inhibitor | 0.091 0.033 DBMET02068 0.09 0.033 DBMET02069 0.09 0.033 DBMET02070 | DBMET02068 | |
| 0.051 | 0.038 | 0.051 | Opioid agonist | |||
| 0.035 | 0.022 | 0.04 | Tubulin agonist | 0.038 0.018 DBMET02068 0.04 0.015 DBMET02069 0.04 0.015 DBMET02070 | DBMET02070 | |
| 0.03 | 0.017 | 0.03 | Nicotinic alpha4beta2 receptor agonist | 0.026 0.023 DBMET02068 | ||
| 0.062 | 0.049 | 0.072 | Neuraminidase (influenza) inhibitor | 0.072 0.033 DBMET02068 0.071 0.033 DBMET02069 0.071 0.033 DBMET02070 | DBMET02068 | |
| 0.023 | 0.011 | 0.023 | Neuraminidase (Influenza B) inhibitor | 0.02 0.016 DBMET02068 | ||
| 0.059 | 0.047 | 0.059 | Carbonic anhydrase inhibitor | 0.054 0.051 DBMET02068 | ||
| 0.038 | 0.026 | 0.038 | Retinoid X receptor antagonist | 0.035 0.032 DBMET02068 | ||
| 0.025 | 0.013 | 0.025 | Beta 1 adrenoreceptor agonist | 0.025 0.013 DBMET02068 0.024 0.014 DBMET02069 0.024 0.014 DBMET02070 | ||
| 0.034 | 0.022 | 0.034 | Liver X receptor beta agonist | |||
| 0.035 | 0.024 | 0.035 | Opioid delta receptor agonist | |||
| 0.122 | 0.112 | 0.125 | Thiol protease inhibitor | 0.125 0.107 DBMET02068 | DBMET02068 | |
| 0.046 | 0.036 | 0.046 | Carnitine palmitoyltransferase 1B inhibitor | |||
| 0.085 | 0.075 | 0.089 | ABCA1 expression enhancer | 0.089 0.067 DBMET02068 | DBMET02068 | |
| 0.046 | 0.036 | 0.048 | Peroxisome proliferator-activated receptor alpha agonist | 0.048 0.034 DBMET02068 0.043 0.038 DBMET02069 0.043 0.038 DBMET02070 | DBMET02068 | |
| 0.089 | 0.079 | 0.099 | Nitric-oxide synthase inhibitor | 0.099 0.062 DBMET02068 0.094 0.07 DBMET02069 0.094 0.07 DBMET02070 | DBMET02068 | |
| 0.019 | 0.01 | 0.019 | Alpha 2a adrenoreceptor agonist | 0.018 0.011 DBMET02068 | ||
| 0.052 | 0.043 | 0.052 | Matrix metalloproteinase (membrane-type) inhibitor | 0.051 0.045 DBMET02068 | ||
| 0.047 | 0.037 | 0.108 | Phosphodiesterase 4A inhibitor | 0.052 0.034 DBMET02068 0.108 0.014 DBMET02069 0.108 0.014 DBMET02070 | DBMET02070 | |
| 0.054 | 0.045 | 0.092 | Fibroblast growth factor 4 antagonist | 0.092 0.012 DBMET02068 0.084 0.016 DBMET02069 0.084 0.016 DBMET02070 | DBMET02068 | |
| 0.041 | 0.032 | 0.041 | Opioid kappa receptor agonist | |||
| 0.015 | 0.006 | 0.016 | Glutamate (mGluR6) agonist | 0.016 0.005 DBMET02068 0.015 0.006 DBMET02069 0.015 0.006 DBMET02070 | DBMET02068 | |
| 0.023 | 0.015 | 0.043 | Dopamine D1 agonist | 0.043 0.005 DBMET02068 0.041 0.005 DBMET02069 0.041 0.005 DBMET02070 | DBMET02068 | |
| 0.022 | 0.014 | 0.024 | Glutaminyl-peptide cyclotransferase inhibitor | 0.022 0.015 DBMET02068 0.024 0.011 DBMET02069 0.024 0.011 DBMET02070 | DBMET02070 | |
| 0.092 | 0.083 | 0.092 | DNA intercalator | |||
| 0.035 | 0.027 | 0.035 | Tryptophan 5 hydroxylase inhibitor | 0.035 0.027 DBMET02068 0.034 0.03 DBMET02069 0.034 0.03 DBMET02070 | ||
| 0.026 | 0.019 | 0.026 | Kynurenine 3 monooxygenase inhibitor | |||
| 0.012 | 0.005 | 0.012 | Progesterone receptor A antagonist | 0.01 0.006 DBMET02068 0.009 0.008 DBMET02069 0.009 0.008 DBMET02070 | ||
| 0.053 | 0.046 | 0.056 | EphB4 antagonist | 0.056 0.042 DBMET02069 0.056 0.042 DBMET02070 | DBMET02070 | |
| 0.033 | 0.026 | 0.033 | Glutamate (mGluR4) agonist | |||
| 0.056 | 0.049 | 0.056 | Acetylcholine M5 receptor antagonist | |||
| 0.047 | 0.04 | 0.047 | Carbonic anhydrase XII inhibitor | 0.045 0.042 DBMET02068 | ||
| 0.013 | 0.006 | 0.013 | Melatonin 2 antagonist | 0.011 0.01 DBMET02068 | ||
| 0.017 | 0.011 | 0.017 | Carbonic anhydrase VIII inhibitor | 0.015 0.014 DBMET02068 | ||
| 0.017 | 0.011 | 0.017 | Carbonic anhydrase X inhibitor | 0.015 0.014 DBMET02068 | ||
| 0.079 | 0.072 | 0.093 | Antiadrenergic | 0.077 0.073 DBMET02068 0.093 0.06 DBMET02069 0.093 0.06 DBMET02070 | DBMET02070 | |
| 0.024 | 0.019 | 0.024 | Methionyl aminopeptidase 2 inhibitor | |||
| 0.055 | 0.049 | 0.055 | Lipocortins synthesis agonist | |||
| 0.032 | 0.027 | 0.032 | Retinoid X alpha receptor agonist | |||
| 0.024 | 0.019 | 0.024 | Lysophosphatidic acid receptor 1 agonist | |||
| 0.033 | 0.028 | 0.039 | Arginase inhibitor | 0.039 0.023 DBMET02068 0.034 0.028 DBMET02069 0.034 0.028 DBMET02070 | DBMET02068 | |
| 0.036 | 0.031 | 0.036 | Potassium channel Kv1.1 blocker | |||
| 0.082 | 0.078 | 0.138 | Platelet activating factor alpha antagonist | 0.081 0.079 DBMET02068 0.138 0.035 DBMET02069 0.138 0.035 DBMET02070 | DBMET02070 | |
| 0.03 | 0.026 | 0.03 | Sirtuin 2 inhibitor | |||
| 0.076 | 0.072 | 0.09 | Adrenaline antagonist | 0.075 0.073 DBMET02068 0.09 0.06 DBMET02069 0.09 0.06 DBMET02070 | DBMET02070 | |
| 0.071 | 0.067 | 0.071 | Acetylcholine nicotinic antagonist | |||
| 0.013 | 0.009 | 0.013 | Lysophosphatidic acid receptor 3 agonist | |||
| 0.07 | 0.066 | 0.07 | Vanilloid 4 agonist | |||
| 0.015 | 0.011 | 0.015 | Purinergic P2Y1 agonist | 0.015 0.012 DBMET02068 | ||
| 0.049 | 0.045 | 0.049 | Carbonic anhydrase II inhibitor | |||
| 0.116 | 0.113 | 0.163 | Cholinergic | 0.135 0.09 DBMET02068 0.163 0.067 DBMET02069 0.163 0.067 DBMET02070 | DBMET02070 | |
| 0.059 | 0.055 | 0.059 | Neuronal nicotinic receptor antagonist | |||
| 0.015 | 0.011 | 0.015 | Thromboxane A2 agonist | |||
| 0.012 | 0.008 | 0.012 | Egl nine homolog 3 inhibitor | |||
| 0.028 | 0.025 | 0.028 | Prostaglandin agonist | |||
| 0.083 | 0.08 | 0.088 | Protein kinase (CK2) inhibitor | 0.088 0.075 DBMET02068 0.083 0.08 DBMET02069 0.083 0.08 DBMET02070 | DBMET02068 | |
| 0.071 | 0.068 | 0.071 | Sphingosine 1-phosphate receptor antagonist | |||
| 0.039 | 0.035 | 0.04 | Leukocyte elastase inhibitor | 0.04 0.033 DBMET02068 | DBMET02068 | |
| 0.045 | 0.042 | 0.045 | Potassium channel (Inward rectifier) blocker | |||
| 0.032 | 0.029 | 0.032 | Retinoid X alpha receptor antagonist | |||
| 0.018 | 0.015 | 0.018 | Methylmalonyl-CoA mutase inhibitor | |||
| 0.062 | 0.059 | 0.062 | Alpha 1b adrenoreceptor antagonist | |||
| 0.145 | 0.142 | 0.19 | Proto-oncogene tyrosine-protein kinase Fyn inhibitor | 0.16 0.118 DBMET02068 0.19 0.083 DBMET02069 0.19 0.083 DBMET02070 | DBMET02070 | |
| 0.024 | 0.022 | 0.024 | CXC chemokine 2 receptor antagonist | |||
| 0.045 | 0.043 | 0.045 | HCV NS3/NS4A protease inhibitor | 0.045 0.043 DBMET02068 | ||
| 0.023 | 0.022 | 0.023 | Sigma 2 receptor antagonist | |||
| 0.076 | 0.075 | 0.076 | Histamine H2 receptor antagonist | |||
| 0.027 | 0.026 | 0.027 | Liver X receptor antagonist | |||
| 0.008 | 0.007 | 0.008 | Thyroid hormone beta agonist | 0.008 0.007 DBMET02068 | ||
| 0.05 | 0.049 | 0.05 | Thromboxane synthase inhibitor | |||
| 0.029 | 0.029 | 0.03 | Peroxisome proliferator-activated receptor delta agonist | 0.03 0.028 DBMET02068 | DBMET02068 | |
| 0.025 | 0.024 | 0.025 | Cyclin E2 inhibitor | |||
| 0.019 | 0.019 | 0.02 | Lysophosphatidic acid 1 receptor antagonist | 0.02 0.018 DBMET02069 0.02 0.018 DBMET02070 | DBMET02070 | |
| 0.015 | 0.015 | 0.015 | G-protein-coupled receptor 120 agonist | 0.015 0.014 DBMET02068 | DBMET02068 | |
| 0.02 | 0.023 | 0.023 | Prostaglandin H2 antagonist | 0.023 0.02 DBMET02068 0.023 0.021 DBMET02069 0.023 0.021 DBMET02070 | DBMET02070 | |
| 0.057 | 0.06 | 0.07 | Peroxisome proliferator-activated receptor gamma agonist | 0.07 0.049 DBMET02068 | DBMET02068 | |
| 0.046 | 0.051 | 0.056 | Phosphodiesterase 4C inhibitor | 0.056 0.039 DBMET02069 0.056 0.039 DBMET02070 | DBMET02070 | |
| 0.004 | 0.009 | 0.008 | Insulin like growth factor 3 antagonist | 0.008 0.003 DBMET02068 0.008 0.003 DBMET02069 0.008 0.003 DBMET02070 | DBMET02070 | |
| 0.058 | 0.066 | 0.075 | Elastase 1 inhibitor | 0.075 0.041 DBMET02068 0.062 0.058 DBMET02069 0.062 0.058 DBMET02070 | DBMET02068 | |
| 0.096 | 0.105 | 0.117 | Proto-oncogene tyrosine-protein kinase Yes inhibitor | 0.117 0.085 DBMET02068 | DBMET02068 | |
| 0.117 | 0.126 | 0.132 | Death-associated protein kinase 1 inhibitor | 0.132 0.075 DBMET02068 0.119 0.116 DBMET02069 0.119 0.116 DBMET02070 | DBMET02068 | |
| 0.071 | 0.081 | 0.088 | Insulin growth factor antagonist | 0.084 0.062 DBMET02068 0.088 0.056 DBMET02069 0.088 0.056 DBMET02070 | DBMET02070 | |
| 0.019 | 0.03 | 0.039 | Leukotriene B4 receptor 1 antagonist | 0.039 0.012 DBMET02068 0.036 0.014 DBMET02069 0.036 0.014 DBMET02070 | DBMET02068 | |
| 0.016 | 0.029 | 0.025 | Leukotriene B4 receptor 2 antagonist | 0.025 0.012 DBMET02068 0.025 0.012 DBMET02069 0.025 0.012 DBMET02070 | DBMET02070 | |
| 0.047 | 0.061 | 0.064 | Neuraminidase inhibitor | 0.064 0.039 DBMET02068 0.062 0.041 DBMET02069 0.062 0.041 DBMET02070 | DBMET02068 | |
| 0.09 | 0.104 | 0.096 | CDC-like kinase 3 inhibitor | 0.096 0.088 DBMET02068 | DBMET02068 | |
| 0.067 | 0.086 | 0.078 | Insulin like growth factor 1 antagonist | 0.074 0.07 DBMET02068 0.078 0.063 DBMET02069 0.078 0.063 DBMET02070 | DBMET02070 | |
| 0.049 | 0.071 | 0.08 | Transcription factor AP-1 inhibitor | 0.075 0.026 DBMET02068 0.08 0.021 DBMET02069 0.08 0.021 DBMET02070 | DBMET02070 | |
| 0.067 | 0.092 | 0.168 | Fibroblast growth factor 1 antagonist | 0.165 0.026 DBMET02068 0.168 0.025 DBMET02069 0.168 0.025 DBMET02070 | DBMET02070 | |
| 0.131 | 0.157 | 0.215 | Platelet aggregation inhibitor | 0.215 0.071 DBMET02069 0.215 0.071 DBMET02070 | DBMET02070 | |
| 0.101 | 0.134 | 0.137 | Neurotrophic factor | 0.131 0.079 DBMET02068 0.137 0.072 DBMET02069 0.137 0.072 DBMET02070 | DBMET02070 | |
| 0.046 | 0.087 | 0.067 | Cyclin B3 inhibitor | 0.067 0.048 DBMET02068 0.062 0.054 DBMET02069 0.062 0.054 DBMET02070 | DBMET02068 | |
| 0.081 | 0.131 | 0.111 | Epidermal growth factor receptor kinase inhibitor | 0.111 0.084 DBMET02069 0.111 0.084 DBMET02070 | DBMET02070 | |
| 0.038 | 0.089 | 0.067 | Protease activated receptor antagonist | 0.067 0.037 DBMET02068 0.059 0.049 DBMET02069 0.059 0.049 DBMET02070 | DBMET02068 | |
| 0.091 | 0.146 | 0.129 | Thrombolytic | 0.128 0.101 DBMET02068 0.129 0.1 DBMET02069 0.129 0.1 DBMET02070 | DBMET02070 | |
| 0.206 | 0.268 | 0.292 | Cyclophilin D inhibitor | 0.292 0.17 DBMET02068 0.241 0.223 DBMET02069 0.241 0.223 DBMET02070 | DBMET02068 | |
| 0.068 | 0.133 | 0.093 | EphA2 antagonist | 0.093 0.084 DBMET02069 0.093 0.084 DBMET02070 | DBMET02070 | |
| 0.049 | 0.117 | 0.089 | Platelet activating factor beta antagonist | 0.089 0.071 DBMET02069 0.089 0.071 DBMET02070 | DBMET02070 | |
| 0.077 | 0.149 | 0.108 | Phosphodiesterase inhibitor | 0.108 0.096 DBMET02069 0.108 0.096 DBMET02070 | DBMET02070 | |
| 0.052 | 0.155 | 0.109 | Platelet activating factor antagonist | 0.109 0.071 DBMET02069 0.109 0.071 DBMET02070 | DBMET02070 | |
| 0.119 | 0.226 | 0.148 | Growth factor agonist | 0.148 0.145 DBMET02068 | DBMET02068 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |